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ABSTRACT 
 
Globally, tuberculosis was the number one infectious disease killer, causing an 
estimated 1.3 million deaths in 2017. TB is also the leading cause of death among people 
living with human immunodeficiency virus (HIV). TB and human HIV infection have 
mutually detrimental effects that complicate patient management and global TB control 
efforts. Epidemiology of TB, drug resistant TB and Mycobacterium tuberculosis (M. 
tuberculosis) strain diversity among people living with HIV in Vietnam have not been 
described previously.  
The overall aim of this thesis was to improve our understanding of the TB 
epidemiology, drug resistance profile, and transmission dynamics among people living 
with HIV in Vietnam. Specific aims were to (i) review TB/HIV co-infection in the Asia-
Pacific region and its contribution to TB recurrence in particular; (ii) to examine the 
contribution of TB/HIV co-infection to the TB epidemic in Vietnam and assess 
improvements in HIV service delivery; (iii) to investigate the rates and mechanisms of 
drug resistance in M. tuberculosis associated with TB/HIV co-infection in Vietnam; (iv) 
to describe the molecular epidemiology and transmission dynamics of M. tuberculosis 
among TB/HIV co-infected individuals in Vietnam; and (v) to explore TB risk factors 
and M. tuberculosis transmission among HIV co-infected individuals in a prospective 
study.  
The global epidemiology of TB, HIV and TB/HIV co-infection in low and high 
incidence countries was examined first with a specific focus on the Asia-Pacific region. 
A geographic overview was then provided describing relevant disease trends within 
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Vietnam, comparing demographic and clinical disease profiles of TB patients with and 
without HIV infection. This review documented the increase in cumulative HIV case 
numbers and deaths between 2005 and 2014 and the decline in new HIV infections and 
HIV-related deaths that could be explained by access to antiretroviral therapy (ART). 
From 2011-2014 routine HIV testing of TB patients increased from 58.9% to 72.5% 
and all TB patients diagnosed with HIV in 2014 received ART.  
Findings from a retrospective study, which analysed 200 M. tuberculosis isolates 
from TB/HIV co-infected patients tested at the Pham Ngoc Thach Hospital 
mycobacterial reference laboratory in Ho Chi Minh city between 2009 and 2014, 
showed that TB/HIV co-infection in Vietnam was associated with high rates of drug 
resistant TB up to 42.0%. Similar to the general population, Beijing and Indo-Oceanic 
lineage strains were most common in TB/HIV co-infected patients. M. tuberculosis 
transmission among people living with HIV appeared to be limited, with most M. 
tuberculosis transmission occurring within the community. Among the transmission 
clusters detected we documented high rates of transmitted drug resistant TB. 
A prospective study aimed to examine TB recurrence and the relative 
contribution of reinfection versus relapse. However, given the improved standard of 
care that people living with HIV receive in Vietnam, we were unable to recruit a 
sufficient number of recurrent TB cases over the 3-year study period. Despite this 
setback, the prospectively collected study cohort of 202 patients did allow us to validate 
the findings from the retrospective study, which was hampered by intermittent and 
potential biased sampling, and to assess both TB and HIV risk factors among TB/HIV 
co-infected individuals in Vietnam. Most TB/HIV co-infected patients were young 
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males, especially in Hanoi where intravenous drug use was a major risk factor for HIV 
acquisition. TB risk factors included delayed ART initiation, limited use of TB 
preventive therapy, high rates of cigarette smoking and substance abuse and possible 
exposure in drug rehabilitation centres. Most cases were severely immune compromised 
at the time of TB, and HIV, diagnosis (median CD4 count 78 cells/mm3). Beijing 
lineage strains predominated in Hanoi and Ho Chi Minh city. There was no indication 
of large scale nosocomial transmission, but some clusters were identified in Hanoi 
among patients with a history of intravenous drug use and rehabilitation.  
The findings from the thesis should help to explain the dynamics of TB disease 
in people living with HIV, improve the care of TB/HIV co-infected patients and the 
control of TB transmission within Vietnam, as well as encourage earlier ART initiation 
and the use of TB preventive therapy in HIV-infected individuals according to World 
Health Organization guidelines. 
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CHAPTER 1 
INTRODUCTION 
1.1. Tuberculosis and HIV co-infection  
TB is among the 10 leading causes of death worldwide and the leading cause from a single 
infectious agent, ranking above human immunodeficiency virus and acquired 
immunodeficiency syndrome (HIV/AIDS). According to World Health Organization 
(WHO) estimates 10.0 million people developed with tuberculosis (TB) in 2017 and 0.9 
million TB cases occurred among people living with HIV/AIDS. TB cases in in the South-
East Asia and Western Pacific Regions account for 58% of the global TB burden (1). 
According to the 2018 WHO Global TB report, the TB incidence worldwide has 
been falling at about 2% per year, but absolute case numbers continue to increase and 16% 
of TB cases still die from their disease. By 2020, annual reductions of at least 4–5% are 
required (with <10% of deaths among TB patients) to reach the first (2020) milestones of 
the End TB Strategy. Regionally, the fastest TB mortality declines occur in Europe and the 
Western Pacific Region (6.0% and 4.6% per year, respectively, since 2010). Most deaths 
from TB could be prevented with early diagnosis and appropriate treatment of TB and HIV. 
In 2017, there were 464,633 TB cases reported among people living with HIV (51% of the 
estimated incidence), of whom 84% were on antiretroviral therapy (ART). The use of TB 
preventive therapy is expanding, especially in people living with HIV, but most eligible 
people are still not accessing it (1). TB preventive treatment was provided to a total of 
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958,559 people in HIV care in 2017, ranging from 1% in Eswatini (formerly Swaziland) 
to 53% in South Africa among those newly enrolled in HIV care (1). 
 
 
Figure 1. Countries in the three high-burden country lists for TB, TB/HIV and MDR-TB 
being used by WHO during the period 2016–2020, and their areas of overlap 1 
 
TB is the leading cause of death even in people living with HIV. Globally, the rate 
of notified TB patients with a documented HIV test result increased slightly from 55% in 
2015 to 60% in 2017 (1, 3).  In total, the African and the South-East Asia regions accounted 
                                              
1 Source: cited from Global tuberculosis report 2018, World Health Organization. 
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for 85% of all TB deaths, with HIV being a major contributor in sub-Saharan Africa (1). 
HIV infection in the Asia-Pacific region is less common than Africa, but the infrastructure 
to deal with TB/HIV co-infected patients is less well developed.  
In 2017, Vietnam ranked 16th among high-burden TB countries and 13th among 
high-burden MDR-TB countries in the world. TB is the second most common infectious 
cause of death in Vietnam, after respiratory infections in general. Vietnam has made 
significant progress in its TB control efforts, achieving Millennium Developmental Goal 
(MDG) targets for reductions in TB incidence, prevalence and mortality well before the 
2015 target date. Before 2015, 100,349 new and recurrent TB cases and 17,000 TB deaths 
were recorded (3). Despite a high burden of TB, Vietnam has a good system of TB 
prevention from the central to grassroots levels, covering the examination, treatment and 
care of people with TB. This demonstrates the high commitments from Vietnam’s leaders 
as well as from the local TB programmes. Patients with TB or diagnosed DR-TB are treated 
as Guidelines on TB diagnostic, treatment and prevention issued by Vietnam Ministry of 
Health which was based on WHO guidelines. The collaboration of the Vietnam National 
Tuberculosis Program and HIV/AIDS program is improving proved by the increasing 
number of tuberculosis cases tested for HIV and receiving antiretroviral therapy (Figure 
2). However, national notification and vital registration systems need to be strengthened to 
measure TB mortality more accurately with better collaboration between TB and HIV 
programs to reduce the burden of TB among people living with HIV (4, 5). 
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Figure 2. Number of tuberculosis cases tested for HIV and receiving antiretroviral 
therapy in Vietnam (2011–2017) 2 
1.2. Emerging drug resistant tuberculosis 
Large numbers of patients with  multi-drug resistant (MDR; resistant to both isoniazid and 
rifampicin) TB, and potential epidemic spread of these drug resistant strains, pose a major 
challenge to global TB control and elimination (6) (7). MDR-TB can be acquired by 
patients who were initially infected with a drug susceptible strain, usually as a result of 
inadequate treatment (so-called secondary or acquired resistance). Alternatively it can  
occur following infection with an MDR strain (so-called primary or transmitted drug 
resistance) (8). A common, but misplaced, assumption has been that MDR-TB among new 
                                              
2 Source: data from Vietnam National Tuberculosis Program (2011-2017) 
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cases provides an accurate reflection of transmitted drug resistance. However, it has been 
demonstrated that many retreatment cases with MDR-TB also represent transmitted drug 
resistance (9) and therefore the contribution of primary MDR-TB transmission has been 
underappreciated for a long time. M. tuberculosis strain diversity, drug resistance and 
transmission among people living with HIV in Vietnam have not been described 
previously. 
In 2017, an estimated 457,560 (82%) MDR-TB cases detected among 558,000 new 
and retreatment cases with rifampicin resistance (RR-TB). Almost half (47%) of these 
cases were in India, China and the Russian Federation (1). An estimated 3.5% of new cases 
and 18% of previously treated cases had R/MDR-TB world-wide, including new and re-
treatment TB cases (1). With current treatment regimens MDR-TB treatment requires 
around 2 years of treatment with toxic second-line TB drugs that are 100 times more 
expensive than first-line treatment. It is estimated that only around 22% of MDR-TB 
patients have access to diagnosis and treatment and treatment outcomes remain sub-optimal 
(1) (10). At least 35 countries have introduced shorter regimens for the treatment of 
R/MDR -TB. There were 8.5% extensively drug-resistant tuberculosis (XDR-TB) among 
MDR-TB cases in 2017 (1).  
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Figure 3. Global distribution and proportions of new TB cases with R/MDR-TB 
phenotype in 2016 3 
 
In Vietnam, resistant TB is on the rise. In 1996, the first national drug resistance 
survey showed that the MDR-TB rate in new patients was 2.3%, in re-treatment patients 
was 32.5%. MDR-TB rate in new patients came up from 2.7% in the third survey in 2005 
to 4% in new patients in the fourth survey in 2011 (4). There was also an increasing MDR-
TB rate in re-treatment patients from 19.0% in the third survey to 23.3% in the fourth 
survey. The number of HIV positive MDR-TB patients who was diagnosed and enrolled 
for treatment was also increasing (Figure 4). 
                                              
3 Source: cited from Global tuberculosis report 2017, World Health Organization. 
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Figure 4. Multidrug resistant tuberculosis cases enrolled for treatment in Vietnam and 
HIV co-infection status (2011–2017) 4 
 
The epidemic spread of MDR-TB is a particular concern in areas with poor control 
of ongoing TB transmission, especially among HIV-infected patients with severe 
immunodeficiency where healthcare facilities can serve as epidemic amplifiers (11) (12). 
Global TB control efforts have been greatly complicated by increased drug resistance and 
                                              
4 Source: data from Vietnam National Tuberculosis Program (2011-2017)  
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the negative synergism of TB and HIV co-infection (13). People living with HIV are at 
greater risk of developing TB than people without HIV, because of their weakened 
immunity. In Viet Nam, persons undergoing HIV testing have not been automatically got 
a TB test under a test and treat policy. The majority of people with HIV who developed 
TB will have ordinary drug susceptible TB and can be treated with standard first-line anti-
TB drugs. However, TB/HIV co-infection in Vietnam has been associated with high rates 
of drug resistance (14), but the genetic determinants of drug resistance remain poorly 
described and a better understanding of TB transmission dynamics is required to guide 
prevention strategies.  
1.3. Molecular epidemiology of M. tuberculosis  
Molecular typing or genotyping of M. tuberculosis introduced the new discipline of 
molecular epidemiology, with the ability to improve our understanding of M. tuberculosis 
transmission dynamics and epidemic spread. Accurate molecular typing can also 
differentiate reinfection from reactivation, detect laboratory cross contamination, allow 
comparison of strains from different geographical regions and provide evolutionary 
insight. It is also helpful in outbreak investigation by assisting tracing of disease origin and 
directionality of infection. However, the use of molecular testing to differentiate 
endogenous reactivation from exogenous reinfection may be more complicated in high 
incidence setting where the same strain may be circulating within the contact circle. Table 
1 introduces common genotyping methods with a brief discussion of advantages and 
limitations.  
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Table 1. Advantages and disadvantages of M. tuberculosis strain typing methods  
Advantages Disadvantages 
IS6110 restriction fragment length polymorphism typing (RFLP) 
Well validated technique 
High discriminatory power in strains with 
multiple IS6110 insertion sites  
High stability (slow insertion rate) 
Requires a viable culture and large 
amount of DNA 
Labor intensive and time consuming 
High level of technical expertise required 
Reproducibility and comparability 
problematic 
Supplementary methods necessary in low 
copy number strains, which have been 
prevalent in South East Asia (15) 
Spoligotyping 
Rapid, reproducible and affordable 
Easy to compare results between 
laboratories  
Does not require a viable culture and only 
small amount of DNA needed 
Good tools for determining strain 
relationships (16, 17) (18) 
Relatively poor discriminatory power 
Inability to differentiate some common 
strain families, Beijing in particular (17) 
Mycobacterial Interspersed Repetitive Unit analysis (MIRU) 
Rapid, reproducible and 
cheaper than RFLP 
Easy to compare results between 
laboratories  
Does not require a viable culture and only 
small amount of DNA needed 
Higher discriminatory power than 
Not always able to obtain complete MIRU 
profile 
Stability/mutation rate unclear 
Limited capacity to distinguish relapse 
from re-infection in outbreak situations 
Beijing lineage isolates requires additional 
analysis (i.e. supplementary loci) for 
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spoligotyping;  MIRU-24 comparable to 
RFLP (19) 
enhanced discriminatory power (20) 
Whole genome sequencing (WGS) 
Benchtop sequencing instruments become 
more affordable 
Ultimate highest discriminatory power; 
unprecedented levels of evolutionary 
insight 
Can infer the likely direction of 
transmission 
Future-proof output 
Expensive and low turn-around times 
(prices and turn-around times dropping 
constantly) 
High level of technical expertise  
Complex quality control requirements to 
ensure harmonization of results 
Complicated bioinformatics and specialist 
software (21) 
 
1.3.1 IS6110 fingerprinting  
The IS6110-RFLP standard developed by Soolingen and colleagues in 1993 using the 
PvuII-restricted enzyme was based on Southern blot analysis (22). It cut the bacterial 
chromosome at IS6110 insertion sites producing segments of variable length that could 
be separated by gel electrophoresis to provide a unique “fingerprint”. Numerous 
national and international databases were established, for example at the Centers for 
Disease Control and Prevention (CDC), Atlanta, Georgia, USA and the Institute for 
Public Health and the Environment, Bilthoven, The Netherlands. 
1.3.2. Spoligotyping  
The spoligotyping technique is based on detecting 43 segments that are most stable and 
diverse in the direct repeat (DR) region. Spoligotyping has the advantage that it can be 
performed directly from a positive sputum specimen and DNA is not required to be 
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clean (17) (23). The combination of IS6110-RFLP and spoligotyping improved strain 
discrimination and a new term phylogeography was coined to describe the geographic 
distribution of various strains and a public database was created to compare and track 
strains from different parts of the world. However, strain resolution was sub-optimal 
and convergent evolution of the DR regions limited evolutionary insight.  
In this thesis, spoligotyping was done on 200 M. tuberculosis isolates of TB/HIV co-
infected patients in retrospective study. 
1.3.3. Mycobacterium interspersed repetitive unit - variable number tandem repeat 
(MIRU-VNTR) typing 
Supply described 12, 15, 24 MIRU-VNTR as a marker for TB classification using 
Polymerase Chain Reaction (PCR). Repeat sequences of each MIRU-VNTR were 
amplified by PCR and gel electrophoresis separated different sized products, equivalent to 
the number of repeats present. Data from MIRU-VNTR could be digitized, making it easy 
to store, analyze and compare the results (24). Its main limitation is inadequate 
differentiation of the highly homologous Beijing strain lineage, which is one of the most 
important lineages globally and the dominant strain lineage in Vietnam. The use of 
additional MIRU loci have been studied to improve resolution of Beijing lineage strains, 
but with limited success.   
In this thesis, 24 MIRU-VNTR was done on 200 M. tuberculosis isolates of TB/HIV co-
infected patients in retrospective study. 
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1.3.4. Whole genome sequencing and single nucleotide polymorphisms   
Unique single nucleotide polymorphisms (SNPs) provide detailed identification of 
individual strains and strain lineages. A whole genome sequencing (WGS) study 
suggested that 45 SNPs could discriminate all the major lineages of M. tuberculosis (24)   
(25). Another study showed that a different set of SNPs could discriminate Beijing 
lineage strains collected from various geographical regions (26). However, with the 
ever-decreasing price of WGS and improvements in bioinformatics, routine WGS 
comparison is rapidly becoming the norm - at least in countries with adequate resources.    
WGS has been applied to strain-specific genotyping and assess drug resistance 
mutations, all in one sample. It offers global comparison of whole genome sequences 
for optimal strain resolution to describe the evolution and spread of M. tuberculosis, 
detect and monitor outbreaks, assess drug-resistance mutations and describe their 
transmission dynamics and evolution over time. WGS has proved as an immensely 
powerful tool to study evolution of pathogens, however, it is still expensive for 
developing countries, remains low turn-around times and requires high level of technical 
expertise and complicated bioinformatics with specialist software. 
In this thesis, WGS was done on 102 M. tuberculosis isolates in retrospective study and 
65 M. tuberculosis isolates of TB/HIV co-infected patients in prospective study. 
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1.4. Study rationale 
This thesis focuses on TB/HIV co-infection in Vietnam, in an attempt to better understand 
the dual epidemic and improve the effectiveness of collaboration between TB and 
HIV/AIDS control programs. A better understanding of M. tuberculosis transmission and 
drug resistance profiles among TB/HIV co-infected patients in Vietnam should provide 
useful guidance to local TB control efforts.  
Vietnam has a high burden of tuberculosis (TB) and multi-drug resistant (MDR) 
TB, but drug resistance patterns and TB transmission dynamics among TB/HIV co-infected 
patients are poorly described. Therefore, this study aimed to examine the transmission 
dynamics and drug resistance conferring mutations in M. tuberculosis strains isolated from 
TB/HIV co-infected patients in Vietnam by employing a variety of molecular methods. 
The research approach taken in this work combined empirical and experimental methods.  
 
1.5. Study setting 
The thesis focused on the two biggest cities in Vietnam: Hanoi and Ho Chi Minh city, 
where we conducted retrospective and prospective studies. Study sites included Hanoi 
Lung Hospital and 09 Hospital (HIV/AIDS Hospital of Hanoi) in North Vietnam and Pham 
Ngoc Thach Hospital in Ho Chi Minh city the South Vietnam . Pham Ngoc Thach Hospital 
is the oldest and largest HIV referral center and diagnoses the largest number of TB/HIV 
co-infected patients in Vietnam. Hanoi Lung Hospital serves as the tertiary referral center 
for TB patients, while 09 Hospital serves as the HIV/AIDS Hospital in Hanoi area. The 
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majority of TB/HIV co-infected patients in Hanoi and Ho Chi Minh city are diagnosed at 
these hospitals. 
The genomics part of this research was conducted at the Centre for Infectious 
Diseases and Microbiology – Public Health, Sydney Medical School and Marie Bashir 
Institute of Infectious Diseases and Biosecurity of The University of Sydney and the New 
South Wales Mycobacterium Reference Laboratory, Institute of Clinical Pathology and 
Medical Research, NSW Health Pathology.  
 
1.6. Research aims and objectives 
1.6.1. Research aim, hypotheses and specific objectives  
The overarching aim of this thesis is to improve our understanding of the molecular 
epidemiology of M. tuberculosis in TB/HIV co-infected patients in Vietnam by leveraging 
recent advances in high-resolution genotyping and transmission mapping.  
 
Our hypotheses were: 
Hypothesis 1:  Phenotypic and genotypic drug resistance is common in M. tuberculosis 
strains isolated from TB/HIV co-infected patients in Vietnam; 
Hypothesis 2: Whole genome sequencing of M. tuberculosis will provide highly 
informative additional insight regarding the drug resistance mechanisms and transmission 
patterns observed; 
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Hypothesis 3: Strains of M. tuberculosis affecting people living with HIV are 
phylogenetically distinct from strains observed in the general community; 
Hypothesis 4: Among HIV-infected patients with TB recurrence, relapse is more common 
than re-infection.  
 
1.6.3. Specific objectives 
Objective 1 (Chapter 2) - To review TB/HIV co-infection in the Asia-Pacific and its 
contribution to TB recurrence in particular;  
Objective 2 (Chapter 3) - To examine the contribution of TB/HIV co-infection to the TB 
epidemic in Vietnam and document responses by the TB and HIV/AIDS control programs;  
Objective 3 (Chapter 4) - To investigate the rates and mechanisms of drug resistance in M. 
tuberculosis in isolates from TB/HIV co-infected patients in Ho Chi Minh city;  
Objective 4 (Chapter 5) - To explore the molecular epidemiology and transmission 
dynamics of M. tuberculosis among TB/HIV co-infected individuals in Ho Chi Minh city;  
Objective 5 (Chapter 6) - To confirm retrospective study findings (objectives 3 & 4) in a 
prospective study and to assess the risk factors associated with TB/HIV co-infection in 
Hanoi and Ho Chi Minh city. Due to low TB recurrence rates we were unable to assess the 
contribution of relapse and re-infection to disease recurrence as originally planned. 
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CHAPTER 2 
The TB/HIV co-infection epidemic in the Asia-Pacific region 
 
Trinh QM, Nguyen HL, Nguyen VN, Nguyen TVA, Sintchenko V, Marais BJ. 
Tuberculosis and HIV co-infection - focus on the Asia-Pacific region. International 
Journal of Infectious Diseases 2015; 32: 170-8. 
 
Trinh Quynh Mai’s contribution to the paper is consistent with her being named the first 
author on the manuscript. The candidate’s contribution to the following items should be 
noted: 
- Conceptualisation of the study and the review of literature 
- Collection and analysis of the data 
- Writing and critical appraisal of the content. 
 
2.1. Preamble 
Unlike sub-Saharan Africa, the Asia-Pacific region which contributes more than a half of 
all TB cases worldwide, reports low rates of TB/HIV co-infection. However, routine testing 
of TB patients for HIV infection is not universally implemented. Although HIV infection 
rates have not seen the rapid rise observed in sub- Saharan Africa, indications are that rates 
are increasing among specific high-risk groups. This paper reviews the risks of TB 
exposure and progression to disease, including the risk of TB recurrence in people living 
with HIV. It also considers the different Mycobacterium tuberculosis strain typing methods 
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used to differentiate re-infection from relapse during TB recurrence. This narrative 
review provides a synthesis of published literature on this topic and describes its current 
state-of-art. 
 
2.2. Key findings  
• Despite reductions in TB case numbers, TB/HIV co-infection seems to be a slowly 
emerging epidemic in the Asia- Pacific region. The double burden of TB and HIV, 
together with increasing rates of MDR-TB, complicates the management of both 
diseases and emphasizes the need for strong coordination between national TB and 
HIV/AIDS control programs.  
• To differentiate re-infection from relapse during TB recurrence, whole genome 
sequencing offers the highest resolution  
• There is urgency to scale up interventions such as intensified TB case-finding, 
isoniazid preventive therapy, and TB infection control, as well as HIV testing and 
improved access to antiretroviral treatment (ART).  
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CHAPTER 3 
The TB/HIV co-infection epidemic in Vietnam 
 
Trinh QM, Nguyen HL, Do TN, Nguyen VN, Nguyen BH, Nguyen TVA, Sintchenko V, 
Marais BJ. Tuberculosis and HIV co-infection in Vietnam. International Journal of 
Infectious Diseases. 2016; 46: 56-60. 
 
Trinh Quynh Mai’s contribution to the paper is consistent with her being named the first 
author on the manuscript. The candidate’s contribution to the following items should be 
noted: 
- Conceptualisation of the study and the review of literature 
- Collection and analysis of the data 
- Coordination of data analysis between Vietnam and Australia 
- Writing and critical appraisal of the content 
 
3.1. Preamble 
Vietnam is ranked 16th among high-burden TB countries in the world. However, TB and 
HIV disease trends and the profile of TB/HIV co-infected patients are poorly described. 
We examined national TB and HIV notification data to provide a geographic overview and 
describe relevant disease trends within Vietnam. We also compared the demographic and 
clinical profiles of TB patients with and without HIV infection in order to understand the 
contribution of TB/HIV co-infection to the TB epidemic in Vietnam. All data was provided 
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by Vietnam National Tuberculosis Program and Vietnam Administration of HIV/AIDS 
control. 
 
3.2. Key findings 
• TB/HIV co-infection remains relatively uncommon in Vietnam with a declining rate 
of HIV infection among TB cases, despite improved rates of HIV testing.    
• From 2005–2014 cumulative HIV case numbers and deaths increased, but access to 
antiretroviral therapy (ART) improved with a considerable decline in new HIV 
infections and deaths. 
•  From 2011-2014 routine HIV testing of TB patients increased dramatically, as did 
access to ART. The number of multidrug resistant (MDR)-TB cases enrolled for 
treatment increased almost 3-fold, without any indication the HIV-infected patients 
were over-represented among MDR-TB cases.  
• TB/HIV service integration has been improving, but greater effort and more 
domestic funding are required to close the gap between service delivery indicators 
and global targets, with special focus on the geographic hot-spot areas identified. 
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CHAPTER 4 
Drug resistance and M. tuberculosis strain diversity in TB/HIV co-infected patients 
in Ho Chi Minh city, Vietnam 
 
Mai TQ, Van Anh NT, Hien NT, Lan NH, Giang DC, Hang PTT, Lan NTN, Marais BJ, 
Sintchenko V. Drug resistance and Mycobacterium tuberculosis strain diversity in TB/HIV 
co-infected patients in Ho Chi Minh City, Vietnam. Journal of Global Antimicrobial 
Resistance 2017; 10: 154-60. 
 
Trinh Quynh Mai’s contribution to the paper is consistent with her being named the first 
author on the manuscript. The candidate’s contribution to the following items should be 
noted: 
- The design of the study 
- Performing spoligotyping and MIRU-24 typing, and gene sequencing (rpoB, katG, 
inhA and inhA promoter, rpsL, rrs and embB) in drug resistant isolates 
- Analysis and interpretation of the findings 
- Writing of the paper and critical appraisal of its content 
 
4.1. Preamble 
Resistance of Mycobacterium tuberculosis (M. tuberculosis) to potent first-line TB drugs, 
particularly isoniazid and rifampicin, presents a serious challenge to global TB control. In 
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2017, Vietnam ranked 16th among high-burden TB countries and 13th among high-burden 
MDR-TB countries in the world. MDR-TB was reported in 4.1% of new and 17% of 
retreatment TB cases.  M. tuberculosis strain diversity and drug resistance among people 
living with HIV in Vietnam have not been well described. We examined M. tuberculosis 
isolates from TB/HIV co-infected patients in Ho Chi Minh city, Vietnam. Drug susceptibility 
testing, spoligotyping and MIRU-24 typing were performed, and the rpoB, katG, inhA and 
inhA promoter, rpsL, rrs and embB genes were sequenced in drug resistant isolates. 
 
4.2. Key findings 
• The two most common lineage strains in M. tuberculosis strains from TB/HIV co-
infected patients were Beijing (49.0%) and East African-Indian (EAI) (35.0%; 
56/70 EAI-5). 
• TB/HIV co-infection was associated with high rates of TB drug resistance; 84/200 
(42.0%) strains demonstrated “any drug resistance”; 
• Streptomycin resistance was most common, being present in 80 (40.0%) isolates; 
17 (8.5%) isolates were MDR; 
• Of the rifampicin resistant strains 16/18 (88.9%) had mutations in the 81-bp 
Rifampicin Resistance Defining Region (RRDR) of the rpoB gene detected by 
Xpert MTB/RIF®. No rifampicin mono-resistance was detected; 
• Isoniazid resistance was mostly associated with Ser315Thr mutations in the katG 
gene (15/17; 88.2%).   
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CHAPTER 5 
Tuberculosis transmission in TB/HIV co-infected patients in Ho Chi Minh city, 
Vietnam 
Mai TQ, Martinez E, Menon R, Van Anh NT, Hien NT, Marais BJ, Sintchenko V. 
Mycobacterium tuberculosis drug resistance and transmission among HIV-infected 
patients in Ho Chi Minh City, Vietnam. American Journal of Tropical Medicine & 
Hygiene. 2018;99(6):1397-406. 
 
Trinh Quynh Mai’s contribution to the paper is consistent with her being named the first 
author on the manuscript. The candidate’s contribution to the following items should be 
noted: 
- Conceptualisation and design of the study 
- Performing culture and genomic DNA extraction from M. tuberculosis isolates  
- Participation in bioinformatics analyses 
- Summative analysis and interpretation of the findings 
- Writing of the paper and critical appraisal of its content 
 
5.1. Preamble 
The epidemic spread of MDR-TB is a particular concern, especially among HIV-infected 
patients with severe immunodeficiency where healthcare facilities can serve as epidemic 
amplifiers. Recently, the availability of WGS as a tool for the diagnosis and clinical 
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management of DR-TB cases, and better targeted TB control efforts, offers considerable 
promise in the fight against TB. We examined the transmission dynamics and drug 
resistance conferring mutations in 200 M. tuberculosis strains isolated (same strains in the 
study in chapter 4) from TB/HIV co-infected patients in Ho Chi Minh city, using a 
combination of spoligotyping, MIRU-VNTR and WGS. In addition, we compared strains 
from our TB/HIV co-infected patient population with publicly available data on 
community isolates from Ho Chi Minh city over similar time period. The cut-off of 10 
SNPs which is used in this study provides a more accurate indication of transmission than 
the 20 SNP cut-off used by Holt et al (who analyzed the data of non-HIV-infected 
individuals in Vietnam). 
5.2. Key findings 
• The majority of TB/HIV co-infected patients were young (162/174; 93.1% <45 
years of age) men (173; 86.5% male); Beijing (98; 49.0%) and Indo-Oceanic (70; 
35.0%) lineage strains were most common.  
• Phenotypic drug resistance was detected in 84 (42.0%) isolates of which 17 (8.5%) 
were MDR; 3 additional MDR strains were identified on WGS.  
• Strain clustering was reduced from 84.0% with spoligotyping to 20.0% with MIRU-
24 to 13.5% with WGS; WGS identified 5 additional clusters, or members of 
clusters, not recognised by MIRU-24.  
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• In total 13 small (2-3 member) WGS clusters were identified, with less clustering 
among drug susceptible (2/27; 7.4%) than drug resistant strains (25/27; 92.6%) (OR 
0.93, 95% CI: 0.77-0.98).  
• No major clusters indicating transmission among people living with HIV were 
noted.  Most strains were interspersed with community strains, indicating TB 
transmission to people living with HIV in the general community.     
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Supplementary Data 
Supplementary Table S1. Phenotypic and genotypic drug resistance identified in sequenced M. tuberculosis strains*  
ID 
Strain 
Lineage 
Phenotypic 
resistance 
detected 
Genotypic resistance detected 
Isoniazid Rifampicin Ethambutol  Pyrazinamide Streptomycin Quinolones 
14-V054 Beijing HSRE katG S315T rpoB H445L embB M306V ND  rpsL K88R ND 
14-V080 Beijing HSRE katG S315T rpoB S450L embB M306I pncA S164 rpsL K88R ND 
10-V021 Beijing HSRE katG S315T rpoB S450L embB M306V pncA F58S rpsL K43R ND 
10-V005 Beijing HSRE katG S315T rpoB D435V embB M306V pncA E181 rpsL K43R ND 
14-V042 Beijing HSRE katG S315T rpoB S450L embB Q497R pncA L151S rpsL K43R ND 
10-V008 Beijing HSRE katG S315T rpoB I491F embB Q497R pncA L19fs rpsL K43R ND 
14-V051 Beijing HSRE katG S315T rpoB S450L embB F330S pncA V131fs rpsL K88R ND 
14-V036 Beijing HSRE katG S315T rpoB H445R embB M306I pncA Q10P rpsL K43R ND 
10-V012 Beijing HSR katG S315T rpoB S450L embB Q497R ND rpsL K88R ND 
14-V081 Beijing HSR katG S315T rpoB S450L embB Q497R ND rpsL K88R ND 
14-V060 Beijing HSR katG S315T rpoB S450L embB M306I pncA A28T rpsL K88R ND 
14-V083 Beijing HSR katG S315T rpoB S450L embB M306I pncA A28T rpsL K88R ND 
10-V014 Beijing HSR 
fabG1 C-15T, 
inhA T17I 
rpoB S450L ND ND rrs A514C ND 
14-V061 Beijing HSR 
fabG1 C-15T, 
 inhA S94A 
rpoB H445Y embB G406S ND rpsL K43R ND 
10-V004 Beijing HS katG S315T ND ND ND rpsL K88R ND 
14-V052 Beijing HS katG S315T ND ND ND rpsL K88R ND 
14-V034 Beijing HS fabG1 C-15T ND ND ND rpsL K88R ND 
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14-V064 Beijing HS fabG1 C-15T ND ND ND rpsL K88R ND 
10-V027 Beijing HS katG S315T ND ND pncA F94L rpsL K88R ND 
10-V029 Beijing HS katG S315T ND ND pncA F94L rpsL K88R ND 
10-V023 Beijing HS katG S315T ND ND ND rpsL K43R ND 
14-V032 Beijing HS katG S315T ND ND ND rpsL K43R ND 
14-V070 Beijing HS katG S315T ND ND ND rpsL K43R ND 
14-V075 Beijing HS katG S315T ND ND ND rpsL K43R ND 
09-V001 Beijing HS katG S315T rpoB I491F embB M306V ND rpsL K43R ND 
14-V062 Beijing HS katG S315T ND ND ND rpsL K43R ND 
14-V073 Beijing HS katG S315T ND ND ND rpsL K43R ND 
14-V076 
Beijing HS 
katG S315T 
36% 
ND ND ND 
rpsL K88R 
34% 
ND 
14-V058 Beijing HS katG S315T ND ND pncA S164 rpsL K43R ND 
14-V037 Beijing HS katG S315T ND ND ND rpsL K88R ND 
14-V050 Beijing SR fabG1 C-15T rpoB S450L embB D354A ND rpsL K43R ND 
14-V039 Beijing S fabG1 C-15T ND ND ND rpsL K88R ND 
14-V082 Beijing S fabG1 C-15T ND ND ND rpsL K88R ND 
14-V045 Beijing S ND ND ND ND rpsL K43R ND 
14-V057 Beijing S ND ND ND ND rpsL K43R ND 
14-V041 Beijing S ND ND ND ND rpsL K43R ND 
14-V068 Beijing S ND ND ND ND rpsL K43R ND 
14-V031 Beijing S ND ND ND ND rpsL A205R ND 
14-V078 
Beijing S ND ND ND ND rpsL K88R 
gyrA 
A90V 
14-V030 Beijing S ND ND ND ND rpsL K88R ND 
14-V074 Beijing S ND ND ND ND rpsL K43R ND 
10-V019 Beijing S ND ND ND ND rrs A514C ND 
14-V072 Beijing S ND ND ND ND rrs A514C ND 
10-V011 Beijing S ND ND ND ND rrs A514C ND 
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10-V020 Beijing S ND ND ND ND rpsL K43R ND 
09-V003 Beijing S ND ND ND ND rpsL K43R ND 
14-V033 Beijing S ND ND ND ND rrs A514C ND 
14-V046 Beijing S ND ND ND ND rrs A517C ND 
14-V066 Beijing S ND ND ND ND ND ND 
14-V084 Beijing S ND ND ND ND ND ND 
14-V067 
Indo-
Oceanic 
HSRE 
fabG1 C-15T, 
inhA S94A 
rpoB H445Y embB G406S ND rpsL K43R ND 
10-V024 
Indo-
Oceanic 
HSRE katG S315T rpoB S450L embB E405D ND gidB F12fs ND 
10-V018 
Indo-
Oceanic 
HSR katG S315T rpoB S450L ND pncA Met1 rpsL K43R ND 
14-V035 
Indo-
Oceanic 
HS fabG1 C-15T ND embB A439T pncA V9A 
gidB L79S, 
gidB A119T 
ND 
14-V038 
Indo-
Oceanic 
HS fabG1 C-15T ND embB A439T pncA V9A 
gidB L79S, 
gidB A119T 
ND 
10-V010 
Indo-
Oceanic 
HS katG S315T rpoB D435Y ND ND rpsL K88R ND 
10-V025 
Indo-
Oceanic 
HS katG S315T ND ND ND 
rpsL K88R, 
gidB A118fs 
ND 
10-V028 
Indo-
Oceanic 
HS katG S315T ND ND ND 
rpsL K88R, 
gidB A118fs 
ND 
14-V063 
Indo-
Oceanic 
HS furA L68F ND ND ND ND ND 
10-V007 
Indo-
Oceanic 
HS katG S315T ND ND ND ND ND 
14-V059 
Indo-
Oceanic 
HS katG S315T ND ND pncA A134Y rpsL K43R ND 
14-V044 
Indo-
Oceanic 
H fabG1 C-15T ND ND pncA -13 C>A ND ND 
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14-V056 
Indo-
Oceanic 
H fabG1 C-15T ND ND pncA -13 C>A ND ND 
10-V026 
Indo-
Oceanic 
H furA L68F ND ND ND ND ND 
10-V006 
Indo-
Oceanic 
S ND ND ND pncA E174K rrs A514C ND 
14-V049 
Indo-
Oceanic 
S ND ND ND pncA E174K rrs A514C ND 
10-V002 
Indo-
Oceanic 
S ND ND ND ND rrs A514C ND 
10-V013 
Indo-
Oceanic 
S ND ND ND ND gidB W45 ND 
10-V015 
Indo-
Oceanic 
S katG P131Q ND ND ND rpsL K43R ND 
10-V016 
Indo-
Oceanic 
S ND ND ND ND rrs A514C ND 
10-V017 
Indo-
Oceanic 
S ND ND ND ND rrs A514C ND 
14-V069 
Indo-
Oceanic 
S ND ND ND ND rpsL K88R ND 
14-V079 
Indo-
Oceanic 
S ND ND ND ND rpsL K88R 
gyrA 
A90V 
14-V040 
Euro-
American 
HS 
katG S315T 
(42%) 
ND ND ND rpsL K88R ND 
14-V043 
Euro-
American 
HS 
katG S315T 
(36%) 
ND ND ND rpsL K88R ND 
14-V047 
Euro-
American 
HS katG S315T ND ND ND ND ND 
14-V048 
Euro-
American 
HS katG S315T ND ND ND gidB R47P ND 
14-V077 
Euro-
American 
H katG S315T ND ND ND ND ND 
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10-V022 
Euro-
American 
S ND ND ND ND gidB fs ND 
14-V053 
Euro-
American 
S ND ND ND ND gidB W45 ND 
14-V055 
Euro-
American 
S ND ND ND ND gidB Trp45 ND 
14-V071 
Euro-
American 
S ND ND ND ND gidB V66fs ND 
10-V009 Other S ND ND ND ND rrs 517C>T ND 
14-V065 Other S ND ND ND ND gidB L91R ND 
14-V194 
Beijing 
Susceptible
  
ND ND ND ND ND 
gyrA 
D94G 
09-V085 
Beijing Susceptible ND ND ND ND ND ND 
09-V088 
Beijing Susceptible ND ND ND ND ND ND 
14-V189 
Beijing Susceptible ND ND ND ND ND ND 
14-V131 
Beijing Susceptible ND ND ND ND ND ND 
14-V145 
Beijing Susceptible ND ND ND ND ND ND 
14-V146 
Beijing Susceptible ND ND ND ND ND ND 
14-V178 
Beijing Susceptible ND ND ND ND ND ND 
10-V113 
Beijing Susceptible ND ND ND ND ND ND 
14-V118 
Beijing Susceptible ND ND ND ND ND ND 
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14-V167 
Beijing Susceptible ND ND ND ND ND ND 
14-V177 
Beijing Susceptible ND ND ND ND ND ND 
14-V187 
Beijing Susceptible ND ND ND ND ND ND 
14-V134 
Indo-
Oceanic 
Susceptible ND ND ND ND gidB A118fs ND 
14-V128 
Indo-
Oceanic 
Susceptible ND ND ND ND ND ND 
14-V154 
Indo-
Oceanic 
Susceptible ND ND ND ND ND ND 
10-V109 
Euro-
American 
Susceptible ND ND ND ND ND ND 
14-V120 
Euro-
American 
Susceptible ND ND ND ND ND ND 
NA – not applicable; H – isoniazid; R – rifampicin; E – ethambutol; S – streptomycin; ND – no relevant mutation detected 
*Sequenced M. tuberculosis strains included all strains with phenotypic resistance to any first-line drug (84) and those that clustered 
by MIRU-24 (an additional 18 drug susceptible strains)   
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Supplementary Table S2. Comparison of M. tuberculosis cluster characteristics among TB/HIV co-infected patients and 
community strains* from Ho Chi Minh City, Vietnam 
Cluster* 
number  
HIV  
Holt**  
cluster 
Terminal 
branch 
length 
Lineage 
Mutations detected 
H R E  Z S Q 
1 
+ NA 5 Beijing katG S315T rpoB S450L embB M306I pncA S164 rpsL K88R ND  
- 103 2 Beijing katG S315T ND ND pncA S164 rpsL K43R ND 
- 103 1 Beijing katG S315T ND ND pncA S164 rpsL K43R ND 
2 
+ NA 0 Beijing ND ND ND ND ND ND 
- NA 1 Beijing ND ND ND ND ND ND 
3 
+ NA 1 Beijing ND ND ND ND ND ND 
- 91 6 Beijing ND ND ND ND ND ND 
4 
+ NA 5 Beijing ND ND ND ND rpsL K43R ND 
+ NA 6 Beijing ND ND ND ND rpsL K43R ND 
- 1 1 Beijing ND ND ND ND rpsL K43R ND 
- 1 4 Beijing ND ND ND ND rpsL K43R ND 
- 1 0 Beijing ND ND ND ND rpsL K43R ND 
5 
+ NA 1 Beijing ND ND ND ND rpsL K43R ND 
- NA 1 Beijing ND ND ND ND rpsL K43R ND 
6 
+ NA 1 Beijing ND ND ND ND rpsL K43R ND 
- 71 8 Beijing ND ND ND ND rpsL K43R ND 
- 71 8 Beijing ND ND ND ND rpsL K43R ND 
- 71 7 Beijing ND ND ND ND rpsL K43R ND 
7 
+ NA 3 Beijing ND ND ND ND AlaArg205 ND 
- NA 3 Beijing ND ND ND ND AlaArg205 ND 
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8 
+ NA 5 
Euro-
American#  
ND ND ND ND 
rrs 
517C>T 
ND 
- 177 7 
Euro-
American#  
ND ND ND ND 
rrs 
517C>T 
ND 
- 177 6 
Euro-
American#  
ND ND ND ND 
rrs 
517C>T 
ND 
- 177 7 
Euro-
American#  
ND ND ND ND 
rrs 
517C>T 
ND 
- 177 2 
Euro-
American#  ND ND ND ND 
rrs  
ND 
C517T 
9 
+ NA 4 
Euro-
American#  
ND ND ND ND L91A ND 
- 172 4 
Euro-
American#  
ND ND ND ND ND ND 
- 172 3 
Euro-
American#  
ND ND ND ND ND ND 
- 172 3 
Euro-
American#  
ND ND ND ND ND ND 
- 172 5 
Euro-
American#  
ND ND ND ND ND 
gyrA 
S91P 
- 172 6 
Euro-
American#  
ND ND ND ND ND ND 
10 
+ NA 0 Indo-Oceanic ND ND ND ND gidB fs ND 
- NA 1 Indo-Oceanic ND ND ND ND gidB fs ND 
11 
+ NA 4 Indo-Oceanic ND ND ND ND gidB W45 ND 
+ NA 1 Indo-Oceanic ND ND ND ND gidB W45 ND 
- 210 5 Indo-Oceanic ND ND ND ND gidB W45 ND 
- 210 7 Indo-Oceanic ND ND ND ND gidB W45 ND 
12 
+ NA 1 Indo-Oceanic furA L68F ND ND ND ND ND 
- NA 4 Indo-Oceanic furA L68F ND ND ND ND ND 
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13 
- NA 5 Beijing ND ND ND ND ND ND 
- NA 1 Beijing ND ND ND ND ND ND 
+ NA 7 Beijing ND ND ND ND rpsL K88R 
gyrA 
A90V 
- ND 4 Beijing ND ND ND ND ND ND 
- ND 2 Beijing ND ND ND ND ND ND 
+ ND 11 Beijing ND ND ND ND ND ND 
- 154 1 Beijing ND ND ND ND ND ND 
- 154 3 Beijing ND ND ND ND ND ND 
- 154 3 Beijing ND ND ND ND ND ND 
- 154 9 Beijing ND ND ND ND ND ND 
- 154 6 Beijing ND ND ND ND ND ND 
- 154 4 Beijing ND ND ND ND ND ND 
- 154 3 Beijing katG S315T ND ND ND ND ND 
- 154 6 Beijing katG S315T ND ND ND ND ND 
- 154 9 Beijing ND ND ND ND ND ND 
- 154 0 Beijing ND ND ND ND ND ND 
- 154 0 Beijing ND ND ND ND ND ND 
14 
+ NA 2 Beijing ND ND ND ND rpsL K88R ND 
- 62 4 Beijing ND ND ND ND rpsL K43R ND 
- 62 6 Beijing ND ND ND ND rpsL K43R ND 
+ NA 5 Beijing ND ND ND ND rpsL K43R ND 
15 
+ NA 1 Beijing ND ND ND ND rrs A514C ND 
- 48 7 Beijing ND ND ND ND rrs A514C ND 
- 48 0 Beijing ND ND ND ND rrs A514C ND 
- 48 3 Beijing ND ND ND ND rrs A514C ND 
- 48 1 Beijing ND ND ND ND rrs A514C 
gyrA 
S91P, 
gyrA 
A90V 
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16 
+ NA 3 Beijing ND ND ND ND rrs A514C ND 
- 48 3 Beijing ND ND ND ND rrs A514C ND 
- 48 3 Beijing ND ND ND ND rrs A514C ND 
17 
+ NA 4 Beijing katG S315T rpoB S450L embB M306V pncA F58S rpsL K43R ND 
- 54 5 Beijing katG S315T rpoB S450L embB M306V pncA F58S rpsL K43R ND 
- 54 2 Beijing katG S315T rpoB S450L embB M306V pncA F58S rpsL K43R ND 
- 54 8 Beijing katG S315T rpoB S450V embB M306V pncA F58S rpsL K43R ND 
18 
+ NA 4 Beijing katG S315T ND ND ND rpsL K43R ND 
- NA 3 Beijing katG S315T ND ND ND rpsL K43R ND 
19 
+ NA 5 Beijing 
fabG1 C-15T, 
inhA T17I 
rpoB S450L ND ND rrs A514C ND 
- 139 3 Beijing fabG1 C-15T ND ND ND rrs A514C ND 
- 139 7 Beijing fabG1 C-15T ND ND ND rrs A514C ND 
- 139 9 Beijing fabG1 C-15T ND ND ND rrs A514C ND 
20 
+ NA 
5 
Indo-Oceanic 
fabG1 C-15T, 
inhA S94A 
rpoB H445Y embB G406D ND rpsL K43R ND 
- NA 3 Indo-Oceanic fabG1 C-15T ND ND ND rpsL K43R ND 
21 
+ NA 5 Beijing ND ND ND ND rpsL K88R ND 
- NA 4 Beijing ND ND ND ND rpsL K88R ND 
Possible 
cluster 1 
+ NA 7 Beijing ND ND ND ND ND ND 
- NA 7 NA ND ND ND ND ND ND 
- NA 12 NA ND ND ND ND ND ND 
Possible 
cluster 2 
+ NA 8 
Euro-
American 
katG S315T ND ND ND ND ND 
- NA 5 NA katG S315T ND ND ND ND ND 
+ NA 10 
Euro-
American 
katG S315T ND ND ND ND ND 
Possible 
cluster 3 
+ NA 11 Beijing katG S315T rpoB D435V embB M306V pncA E181 rpsL K43R ND 
- NA 7 NA katG S315T rpoB -6T>C ND ND rpsL K43R ND 
+ NA 4 Beijing katG S315T rpoB S450L embB Q497R 
pncA 
L151S 
rpsL K43R ND 
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Possible 
cluster 4 
+ NA 11 Beijing katG S315T ND ND ND rpsL K43R ND 
- 121 6 NA katG S315T rpoB S450L ND ND rpsL K88R ND 
Possible 
cluster 5 
+ NA NA Beijing ND ND ND ND ND ND 
- 121 11 NA katG S315T rpoB L430P embB G406D ND rpsL K88R ND 
Possible 
cluster 6 
+ NA 11 Beijing katG S315T ND ND pncA S164 rpsL K43R ND 
- 103 5 NA katG S315T ND embB M306V ND rpsL K43R ND 
- 103 6 NA katG S315T ND ND ND rpsL K43R ND 
- 103 1 NA katG S315T ND ND ND rpsL K43R ND 
- 103 0 NA katG S315T ND ND ND rpsL K43R ND 
- 103 5 NA katG S315T ND ND ND rpsL K43R ND 
Possible 
cluster 7 
+ NA 18 Indo-Oceanic katG S315T rpoB S450L ND pncA Met1 rpsL K43R ND 
- NA 5 NA ND ND ND ND ND ND 
- NA NA NA ND ND ND ND ND ND 
- NA NA NA ND ND ND ND ND ND 
- NA NA NA ND ND ND ND ND ND 
Possible 
cluster 8 
+ NA 8 Beijing katG S315T rpoB H445R embB M306I pncA Q10P rpsL K43R ND 
- NA 10 NA katG S315T ND ND ND rpsL K43R ND 
Possible 
cluster 9 
+ NA 10 Beijing katG S315T ND ND ND rpsL K88R ND 
- 73 15 NA fabG1 C-15T rpoB S450L ND ND rpsL K88R ND 
- 73 8 NA katG S315T rpoB S450W ND ND rpsL K88R ND 
- 73 12 NA katG S315T ND ND ND rpsL K88R ND 
- NA NA NA ND ND ND ND ND ND 
TB – tuberculosis; HIV – human immunodeficiency virus; NA – not available in Holt et.al (1) data; ND – no relevant mutation 
detected; - negative; + positive; INH – isoniazid; RMP – rifampicin; EMB – ethambutol; STR – streptomycin; FQ – Quinolones;  
* WGS cluster identified as ≤10 SNPs difference, “possible cluster” as 10-20 SNPs difference  
** Cluster and sequence data for community M. tuberculosis strains were derived from Holt et.al (1).  
# Euro-American lineage – sub-lineage MANU  
(1) Holt KE, McAdam P, Thai PVK, Thuong NTT, Ha DTM, Lan NN, et al. Frequent transmission of the Mycobacterium tuberculosis 
Beijing lineage and positive selection for the EsxW Beijing variant in Vietnam. Nature genetics. 2018;50(6):849-56  
 95 
 
Supplementary Table S3. Information of all sequenced isolates 
No ID Cluster 
No of SNP 
differences 
Year of 
isolation 
Lineage 
Phenotypic 
resistance 
detected 
Genotypic resistance detected 
H R E Z S Q 
1 
10-
V027 
1.WGS 
0 2010 Beijing HS katG S315T ND ND 
pncA 
F94L 
rpsL K43R ND 
2 
10-
V029 
0 2010 Beijing HS katG S315T ND ND 
pncA 
F94L 
rpsL K43R ND 
3 
10-
V109 
2.WGS 
1 2010 
Euro-
American 
Susceptible ND ND ND ND ND ND 
4 
14-
V120 
3 2014 
Euro-
American 
Susceptible ND ND ND ND ND ND 
5 
14-
V064 
3.WGS 
5 2014 Beijing HS fabG1 -15C>T ND ND ND rpsL K43R ND 
6 
14-
V082 
3 2014 Beijing S fabG1 -15C>T ND ND ND rpsL K43R ND 
7 
14-
V053  
4.WGS 
4 2014 
Euro-
American 
S ND ND ND ND gidB Trp45 ND 
8 
14-
V055 
1 2014 
Euro-
American 
S ND ND ND ND gidB W45 ND 
9 
10-
V010 
5.WGS 
1 2010 
Indo-
Oceanic 
HS katG S315T 
rpoB 
D435Y 
ND ND rpsL K88R ND 
10 
10-
V025 
1 2010 
Indo-
Oceanic 
HS katG S315T ND ND ND 
gidB L88T, 
gidB 
R118fs 
ND 
11 
10-
V028 
1 2010 
Indo-
Oceanic 
HS katG S315T ND ND ND 
gidB L88T, 
gidB 
R118fs 
ND 
12 
10-
V012 
 
6.WGS 
0 2010 Beijing HSR katG S315T 
rpoB 
S450L 
embB 
Q497R 
ND rpsL K88R ND 
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13 
14-
V081 
2 2014 Beijing HSR katG S315T 
rpoB 
S450L 
embB 
Q497R 
ND rpsL K88R ND 
14 
14-
V030 7.WGS 
 
2 2014 Beijing S ND ND ND ND rpsL K43R ND 
15 
14-
V074 
5 2014 Beijing S ND ND ND ND rpsL K43R ND 
16 
14-
V060 
8.WGS 
1 2014 Beijing HSR katG S315T 
rpoB 
S450L 
embB 
M306I 
pncA 
A28T 
rpsL K88R ND 
17 
14-
V083 
0 2014 Beijing HSR katG S315T 
rpoB 
S450L 
embB 
M306I 
pncA 
A28T 
rpsL K88R ND 
18 
14-
V034 
9.WGS 
3 2014 Beijing HS fabG1 -15C>T ND ND ND rpsL K43R ND 
19 
14-
V039 
4 2014 Beijing S fabG1 -15C>T ND ND ND rpsL K43R ND 
20 
14-
V035 
10.WGS 
3 2014 
Indo-
Oceanic 
HS fabG1 C-15T ND 
embB 
A439T 
pncA 
V9A 
gidB L79S, 
gidB 
A119T 
ND 
21 
14-
V038 
4 2014 
Indo-
Oceanic 
HS fabG1 -15C>T ND 
embB 
A439T 
pncA 
V9A 
gidB L79S, 
A119T 
ND 
22 
10-
V006 
11.WGS 
1 2010 
Indo-
Oceanic 
S ND ND ND 
pncA 
E174K 
rrs A514C ND 
23 
14-
V049 
2 2014 
Indo-
Oceanic 
S ND ND ND 
pncA 
E174K 
rrs A514C ND 
24 
14-
V044 
12.WGS 
2 2014 
Indo-
Oceanic 
H fabG1 -15C>T ND ND 
pncA -
13 C>A 
ND ND 
25 
14-
V056 
3 2014 
Indo-
Oceanic 
H fabG1 -15C>T ND ND 
pncA -
13 C>A 
ND ND 
26 
14-
V040 
13.WGS 
0 2014 
Indo-
Oceanic 
HS 
katG S315T 
(42%) 
ND ND ND rpsL K88R ND 
27 
14-
V043 
0 2014 
Euro-
American 
HS 
katG S315T 
(36%) 
ND ND ND rpsL K88R ND 
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28 
10-
V004 
  2010 Beijing HS katG S315T ND ND ND rpsL K88R ND 
29 
14-
V052 
  2014 Beijing HS katG S315T ND ND ND rpsL K88R ND 
30 
14-
V054 
  2014 Beijing HSRE katG S315T 
rpoB 
H445L 
embB 
M306V 
ND rpsL K88R ND 
31 
14-
V080 
  2014 Beijing HSRE katG S315T 
rpoB 
S450L 
embB 
M306I 
pncA 
S164 
rpsL K88R ND 
32 
09-
V085 
  2009 Beijing Susceptible ND ND ND ND ND ND 
33 
09-
V088 
  2009 Beijing Susceptible ND ND ND ND ND ND 
34 
14-
V045 
  2014 Beijing S ND ND ND ND rpsL K43R ND 
35 
14-
V057 
  2014 Beijing S ND ND ND ND rpsL K43R ND 
36 
14-
V041 
  2014 Beijing S ND ND ND ND rpsL K43R ND 
37 
14-
V068 
  2014 Beijing S ND ND ND ND rpsL K43R ND 
38 
14-
V031 
  2014 Beijing S ND ND ND ND 
gidB 
A205R 
ND 
39 
10-
V009 
  2010 Other S ND ND ND ND rrs C517T ND 
40 
14-
V065 
  2014 Other S ND ND ND ND gidB L91R ND 
41 
10-
V022 
  2010 
Euro-
American 
S ND ND ND ND gidB fs ND 
42 
14-
V063 
  2014 
Indo-
Oceanic 
HS furA L68F ND ND ND ND ND 
43 
10-
V019 
  2010 Beijing S ND ND ND ND rrs A514C ND 
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44 
14-
V072 
  2014 Beijing S ND ND ND ND rrs A514C ND 
45 
10-
V021 
  2010 Beijing HSRE katG S315T 
rpoB 
S450L 
embB 
M306V 
pncA 
F58S 
rpsL K43R ND 
46 
10-
V023 
  2010 Beijing HS katG S315T ND ND ND rpsL K43R ND 
47 
14-
V078 
  
 2014 Beijing S ND ND ND ND rpsL K88R 
gyrA 
A90V 
48 
14-
V189 
  2014 Beijing Susceptible ND ND ND ND ND ND 
49 
10-
V014 
  2010 Beijing HSR 
fabG1 -15C>T, 
inhA T17I 
rpoB 
S450L 
ND ND rrs A514C ND 
50 
14-
V131 
  2014 Beijing Susceptible ND ND ND ND ND ND 
51 
10-
V007 
  2010 
Euro-
American 
HS katG S315T ND ND ND ND ND 
52 
14-
V077 
  2014 
Euro-
American 
H katG S315T ND ND ND ND ND 
53 
10-
V005 
  2010 Beijing HSRE katG S315T 
rpoB 
D435V 
embB 
M306V 
pncA 
E181 
rpsL K43R ND 
54 
14-
V042 
  2014 Beijing HSRE katG S315T 
rpoB 
S450L 
embB 
Q497R 
pncA 
L151S 
rpsL K43R ND 
55 
14-
V032 
  2014 Beijing HS katG S315T ND ND ND rpsL K88R ND 
56 
14-
V145 
  2014 Beijing Susceptible ND ND ND ND ND ND 
57 
14-
V146 
  2014 Beijing Susceptible ND ND ND ND ND ND 
58 
10-
V011 
  2010 Beijing S ND ND ND ND ND ND 
59 
10-
V020 
  2010 Beijing S ND ND ND ND rrs A514C ND 
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60 
10-
V026 
  2010 
Indo-
Oceanic 
H furA L68F ND ND ND ND ND 
61 
14-
V047 
  2014 
Euro-
American 
HS katG S315T ND ND ND ND ND 
62 
14-
V059 
  2014 
Indo-
Oceanic 
HS katG S315T ND ND 
pncA 
A134Y 
rpsL K43R ND 
63 
14-
V061 
  2014 Beijing HSR 
fabG1 -15C>T, 
inhA S94A 
rpoB 
H445Y 
embB 
G406S 
ND rpsL K43R ND 
64 
14-
V067 
  2014 
Indo-
Oceanic 
HSRE 
fabG1 -15C>T, 
inhA S94A 
rpoB 
H445Y 
embB 
G406S 
ND rpsL K43R ND 
65 
14-
V070 
  2014 Beijing HS katG S315T ND ND ND rpsL K43R ND 
66 
14-
V075 
  2014 Beijing HS katG S315T ND ND ND rpsL K43R ND 
67 
14-
V178 
  2014 Beijing Susceptible ND ND ND ND ND ND 
68 
09-
V001 
  2009 Beijing HS katG S315T 
rpoB 
I491F 
embB 
M306V 
ND rpsL K43R ND 
69 
10-
V002 
  2010 
Indo-
Oceanic 
S ND ND ND ND rrs A514C ND 
70 
09-
V003 
  2009 Beijing S ND ND ND ND rpsL K43R ND 
71 
10-
V008 
  2010 Beijing HSRE katG S315T 
rpoB 
I491F 
embB 
Q497R 
pncA 
L19fs 
rpsL K43R ND 
72 
10-
V013 
  2010 
Indo-
Oceanic 
S ND ND ND ND gidB W45 ND 
73 
10-
V015 
  2010 
Indo-
Oceanic 
S katG P131Q ND ND ND rpsL K43R ND 
74 
10-
V016 
  2010 
Indo-
Oceanic 
S ND ND ND ND rrs A514C ND 
75 
10-
V017 
  2010 
Indo-
Oceanic 
S ND ND ND ND rrs A514C ND 
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76 
10-
V024 
  2010 
Indo-
Oceanic 
HSRE katG S315T 
rpoB 
S450L 
embB 
E405D 
ND gidB F12fs ND 
77 
14-
V033 
  2014 Beijing S ND ND ND ND rpsL K43R ND 
78 
14-
V046 
  2014 Beijing S ND ND ND ND rrs A514C ND 
79 
14-
V048 
  2014 
Euro-
American 
HS katG S315T ND ND ND gidB R47P ND 
80 
14-
V050 
  2014 Beijing SR fabG1 -15C>T 
rpoB 
S450L 
embB 
D354A 
ND rpsL K43R ND 
81 
14-
V051 
  2014 Beijing HSRE katG S315T 
rpoB 
S450L 
embB 
F330S 
pncA 
V131fs 
rpsL K88R ND 
82 
14-
V062 
  2014 Beijing HS katG S315T ND ND ND rpsL K43R ND 
83 
14-
V066 
  2014 Beijing S ND ND ND ND rrs A517C ND 
84 
14-
V069 
  2014 
Indo-
Oceanic 
S ND ND ND ND rpsL K88R ND 
85 
14-
V071 
  2014 
Euro-
American 
S ND ND ND ND gidB V66fs ND 
86 
14-
V073 
  2014 Beijing HS katG S315T ND ND ND rpsL K43R ND 
87 
14-
V076 
  2014 Beijing HS 
katG S315T 
(36%) 
ND ND ND 
rpsL K88R 
(34%) 
ND 
88 
14-
V079 
  2014 
Indo-
Oceanic 
S ND ND ND ND rpsL K88R 
gyrA 
A90V 
89 
14-
V084 
  2014 Beijing S ND ND ND ND ND ND 
90 
10-
V113 
  2010 Beijing Susceptible ND ND ND ND ND ND 
91 
14-
V118 
  2014 Beijing Susceptible ND ND ND ND ND ND 
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92 
14-
V128 
  2014 
Indo-
Oceanic 
Susceptible ND ND ND ND ND ND 
93 
14-
V134 
  2014 
Indo-
Oceanic 
Susceptible ND ND ND ND 
gidB 
R118fs 
ND 
94 
14-
V154 
  2014 
Indo-
Oceanic 
Susceptible ND ND ND ND ND ND 
95 
14-
V167 
  2014 Beijing Susceptible ND ND ND ND ND ND 
96 
14-
V177 
  2014 Beijing Susceptible ND ND ND ND ND ND 
97 
14-
V187 
  2014 Beijing Susceptible ND ND ND ND ND ND 
98 
14-
V194 
  2014 Beijing Susceptible ND ND ND ND ND 
gyrA 
D94G 
99 
14-
V058 
  2014 Beijing HS katG S315T ND ND 
pncA 
S164 
rpsL K43R ND 
100 
10-
V018 
  2010 
Indo-
Oceanic 
HSR katG S315T 
rpoB 
S450L 
ND 
pncA 
Met1 
rpsL 
K43R; rrs 
1401A>G 
ND 
101 
14-
V036 
  2014 Beijing HSRE katG S315T 
rpoB 
H445R 
embB 
M306I 
pncA 
Q10P 
rpsL K43R ND 
102 
14-
V037 
  2014 Beijing HS katG S315T ND ND ND rpsL K88R ND 
ND – no relevant mutation detected; H – isoniazid; R – rifampicin; E – ethambutol; S – streptomycin; F – Quinolones;  
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Supplementary Figure S1. Comparison of M. tuberculosis branch length in HIV-infected patients by age group 
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CHAPTER 6 
Tuberculosis risk factors and Mycobacterium tuberculosis transmission among HIV-
infected patients in Vietnam  
 
Mai TQ, Martinez E, Menon R, Van Anh NT, Hien NT, Lan NH, Giang DC, Hang PT, 
Thuong PH, Huan HV, Hoang NP, Nhung NV, Marais BJ, Sintchenko V. Tuberculosis risk 
factors and Mycobacterium tuberculosis transmission among HIV-infected patients in 
Vietnam. Tuberculosis 2019. (in press). 
 
Trinh Quynh Mai’s contribution to the paper is consistent with her being named the first 
author on the manuscript. The candidate’s contribution to the following items should be 
noted: 
- Conception and design of the research 
- Performing culture and genomic DNA extraction from M. tuberculosis isolates 
- Participation in bioinformatics analyses of sequenced genomes 
- Synthesis of epidemiological, clinical and genomic data 
- Analysis and interpretation of the findings 
- Writing of the paper and critical appraisal of its content 
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6.1. Preamble 
Our findings from retrospective study concluded that recent transmission of tuberculosis 
among HIV-infected individuals appeared to be limited and TB/HIV co-infection in 
Vietnam was associated with high rates of drug resistance in Mycobaterium tuberculosis 
(M. tuberculosis). We continued our study on prospective isolates to confirm our findings 
from retrospective study. Although a 5 SNP cut-off is more conservative, the cut-off of 10 
SNPs using in this study provides a fair indication of recent transmission and excludes the 
risk of underestimation given that we had very limited epidemiological data. 
 
6.2. Key findings 
Risk factors for TB/HIV co-infection included young age (170; 84.2% <45 years of age), 
being male (159; 86.5%), and intravenous drug use (69; 34.2%), especially in Hanoi 
(30/46; 65.2). In nearly 50% of cases (100; 49.5%) the TB presentation prompted their HIV 
diagnosis. Compared to whole genome sequencing (WGS), GeneXpert MTB/RIF® missed 
6 rifampicin resistant cases, 2 with mutations outside the rifampicin resistance determining 
region (RRDR). WGS genotyping identified three clusters, all in Hanoi, suggestive of 
either nosocomial transmission or recent transmission in the community. Delayed 
antiretroviral therapy initiation and poor TB preventive therapy uptake were identified as 
major TB risk factors. There was limited evidence of recent TB transmission among 
TB/HIV co-infected patients. 
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CHAPTER 7 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
7.1. Drawing the findings together 
Tuberculosis remains the most prevalent infectious disease worldwide, with one third of 
the world’s population currently infected. Molecular typing and genome sequencing of 
Mycobacterium tuberculosis (M. tuberculosis) has significantly increased our capacity to 
monitor TB transmissions and to prevent secondary cases. In this thesis the attempt was 
made to address a gap in our understanding of epidemiology and genomics of 
Mycobacterium tuberculosis in TB/HIV co-infection in Vietnam. This study tested the 
hypotheses that phenotypic and genotypic drug resistance is common in M. tuberculosis 
strains isolated from TB/HIV co-infected patients in Vietnam. 
 This research was heavily based on high-resolution methods of genotyping of M. 
tuberculosis and differs from previous work in that it examined TB/HIV co-infection cases 
not subjected to critical analysis before; focused on highly granular genomic data, in the 
context of TB management in the country with relatively high incidence of tuberculosis. It 
was postulated that careful documentation would reduce the fragmentation and improve 
the effectiveness of collaboration between national and local TB and HIV/AIDS control 
programs. A better understanding of M. tuberculosis transmission pathways, associated 
risk factors and drug resistance profiles should provide useful guidance to local TB control 
efforts. 
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 This thesis offers novel insights in the molecular epidemiology of tuberculosis, 
transmission pathways and molecular mechanisms of drug resistance to the first line 
antituberculous agents in Vietnam. This chapter draws together the findings of the 
empirical work and discusses their implications for future research. The following sections 
address specific findings related to individual objectives of the study. 
 
Objective 1. To review TB/HIV co-infection in Asia-Pacific and its contribution to TB 
recurrence in particular (Chapter 2) and Objective 2. To examine the contribution of 
TB/HIV co-infection to the TB epidemic in Vietnam (Chapter 3). 
We have observed that TB/HIV co-infection did not appear to be a major driver of 
the TB epidemic in the Asia-Pacific region, although HIV infection rates were high among 
certain groups. In Vietnam, people living with HIV and TB mainly reside in large cities 
and the mountainous, hard to reach, provinces. TB/HIV co-infection in Vietnam has been 
relatively uncommon with continuous declining rate of HIV positive in TB cases from 5% 
in 2015 to 4% in 2016 (1) (3). The rate of HIV co-infection in MDR and non-MDR TB 
cases was found similar in 2014 without any indication the HIV-infected patients were 
over-represented among MDR-TB cases. The development of MRD-TB has not been not 
‘‘driven’’ by HIV co-infection. Moreover, it was necessary to increase the number of 
persons with TB having HIV testing and TB patients living with HIV in order to achieve 
higher uptake of antiretroviral therapy, and to scale up TB preventive treatment among 
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people living with HIV to reduce TB incidence and associated mortality in sites with high 
ART coverage in Vietnam. 
 
Objective 3. To investigate the rates and mechanisms of drug resistance in M. tuberculosis 
in isolates from TB/HIV co-infected patients in Ho Chi Minh City (Chapter 4). 
The first study examined the rate of drug resistance in M. tuberculosis in isolates 
from TB/HIV co-infected patients in Vietnam with findings of high rates of TB drug 
resistance, especially in vitro resistance to streptomycin. In Vietnam this can be partially 
explained by a cultural preference for intramuscular injections and the fact that 
streptomycin was used during the intensive phase of standard first-line treatment in 
preference to ethambutol until 2016. Our findings also extended the catalogue of genomic 
changes that can be used to infer drug resistance in strains circulating in South East Asia. 
The finding that the two most common lineage strains in M. tuberculosis strains from 
TB/HIV co-infected patients were Beijing and East-African-Indian re-confirmed the 
previous reports from other studies in different TB affected groups in Vietnam. 
 
Objective 4. To explore the molecular epidemiology and transmission dynamics of M. 
tuberculosis among TB/HIV co-infected individuals in Ho Chi Minh City (Chapter 5). 
The results of Objective 4 extended and confirmed findings from Objective 3 about 
the limited role of M. tuberculosis transmission among HIV-infected patients. Our findings 
documented that Beijing lineage is the most predominant phylogenetic lineage of M. 
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tuberculosis and the Indo-Oceanic lineage is the second common lineage responsible for 
human tuberculosis in Vietnam. During the implementation of the study, we also 
documented the discordant phenotypic and genotypic streptomycin resistance profiles, 
which could be due to inaccurate phenotypic direct susceptibility testing results or culture 
contamination. This raises the concern of ensuring quality management in the relevant 
laboratories including external quality assurance for specimen processing and drug 
susceptible testing (DST). Our findings indicate that combination of spoligotyping and 
MIRU-24 typing remains a suitable approach to identify and differentiate M. tuberculosis 
sub-lineages and clusters of isolates in high-incidence countries. Furthermore, such 
approach is easy to implement and harmonise between laboratories in a developing country 
like Vietnam. Drug resistance has been inferred from in vitro DST and/or PCR-based 
methods. However, whole genome sequencing (WGS)-based approach appears to provide 
more comprehensive information of lineage identification, drug resistant TB and new 
mutations coffering drug resistance, TB transmission or transmission dynamics at highest 
discriminatory power as well as unprecedented levels of evolutionary insight. The 
application of WGS is necessary to utilize what this technique can provide for the 
understanding of drug resistance, TB transmission or transmission dynamics in Vietnam. 
However, the usage efficiency and requirement of high level of technical and 
bioinformatics expertise, complex quality control requirements, computing infrastructure 
and specialist software are also big challenges for the public health laboratories in Vietnam. 
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Our findings brought the attention onto potential limitations of PCR-based drug 
resistance detection. The detection of rpoB mutations outside the 81-bp Rifampicin 
Resistance Defining Region (RRDR) that would have not been recognised by GeneXpert 
MTB/RIF® emphasised the challenges of relying on a single gene PCR approach, even by 
the new Ultra version. It is expected that new mutations outside of the 81-bp RRDR in our 
prospective isolates should be detected by WGS. The results from our prospective study 
indeed demonstrated that there was the missed diagnosis in rifampicin resistant cases that 
was outside the Xpert region of detection. Even more concerning, a few cases with typical 
mutations inside rpoB gene RRDR were also missed by Xpert. This could lead to 
suboptimal TB treatment regimen applied for those who had rifampicin resistance. This 
study recommends the extension of the range of relevant mutations associated with 
clinically relevant rifampicin resistance that should be captured by the next version of 
Xpert MTB/RIF® assay. WGS-guided innovative approached to TB preventive treatment 
and ART initiation for HIV patients can improve the quality and efficiency of TB/HIV 
management in Vietnam.  
The phylogenetic analysis of sequenced M. tuberculosis strains from patients with 
TB/HIV co-infection from retrospective study and non-HIV infected patients showed that 
TB/HIV co-infection in Vietnam was associated with high rates of drug resistance and low 
risk of M. tuberculosis transmission among HIV-infected patients. Moreover, we also 
wanted to understand whether our findings that transmission among HIV-infected 
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individuals appears to be limited from retrospectively reviewed cases can be reproduced 
and confirmed by using WGS of M. tuberculosis from prospectively enrolled cases. 
 
Objective 5. To confirm retrospective study findings (Objectives 3 & 4) in a prospective 
study of M. tuberculosis transmission and to assess the risk factors associated with TB/HIV 
co-infection in Hanoi and Ho Chi Minh City (Chapter 6). 
The phylogenetic analysis of sequenced M. tuberculosis strains from prospective 
and retrospective study and non-HIV infected patients/community indicated that M. 
tuberculosis transmission among HIV-infected patients in Vietnam was uncommon. 
Results from prospective study confirm our conclusion that transmission among HIV-
infected individuals appears to be relatively limited. It would be beneficial if other TB/HIV 
care centres in the country could collect and review similar data, since it could identify 
local infection control issues. We believe that the findings of this study will contribute 
useful information for TB and HIV/AIDS control programs in Vietnam.  
Significant risk factors for tuberculosis among HIV-infected patients in Vietnam 
were the young age, being a male and having the delayed treatment of HIV. The 
significance of other risk factors, such as history of incarceration, cigarette smoking, 
excessive alcohol intake, low CD4 cell count were difficult to establish due to low numbers 
of patients included in analysis. Implementation of World Health Organization guidelines, 
rapid TB diagnostics and TB drug susceptibility testing for all patients should remain a 
priority in this region. The main limitations of this study were (i) collection of data and 
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samples only in two cities of the country, and (ii) unexpectedly low TB recurrence rates 
which complicated assessment of the contribution of relapse and re-infection to disease 
recurrence as originally planned.  
Main limitations were outlined in our studies including: 
- Retrospective study: It only includes a limited of consecutive isolates number of 
TB/HIV co-infected patients diagnosed in Ho Chi Minh city, which may not be 
representative of all TB/HIV co-infected patients in Vietnam. Although continuous 
sample collection would have been preferable and most comparable to methods used 
by Holt et.al., we believe our findings remain informative given that consecutive 
sample collection was unbiased and the sampling periods broadly comparable. We 
cannot rule out the possibility that some of the TB cases included in Holt’s study of 
HIV-uninfected individuals in 2008-2011 may have represented as HIV-infected 
patients with a TB relapse episode in 2014.   
- Prospective study: Study limitations include the exclusion of cases with Xpert 
positive rifampicin resistance, which limits our ability to comment on drug 
resistance patterns. Since no phenotypic DST was performed, discrepancies 
between phenotypic and genotypic DST profiles were not considered. The low 
culture yield observed probably reflects the fact that many patients were recruited 
into the study after initiation of TB treatment at the referring facility. The cluster 
definition used (<10 SNPs) may be too sensitive for a high incidence setting, as 
suggested by the fact clustered cases were referred from different District 
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Tuberculosis Units without any identifiable epidemiological links. Lastly, 
comments on replapse versus reinfection could not done due to low rate recurrence 
during this study period.  
In general, the study provided novel and important information to microbiologists, 
clinicians, epidemiologists, public health professionals and researchers working in 
Vietnam and internationally. This information will assist them in evaluation of the rates of 
TB drug resistance, resistance mutations, lineage/sub-lineage characteristics, risk factors 
in H patients, thus contributing to the forecasting, planning and guiding strategies for 
effective TB control for HIV/AIDS patients in Vietnam. 
The study suggested recommendation and justification of more TB preventive 
treatment and antiretroviral treatment (ART) initiation for HIV patients in order to further 
improve the quality and efficiency of TB/HIV management in Vietnam. This should 
facilitate the coordination plan between the national target program on HIV and the project 
on TB prevention and control under the national target program, contributing to reducing 
the mortality rate and improvement of quality of life in TB/HIV patients as well as 
improving quality of health care for the Vietnamese people. 
 
7.2. Future directions 
The prospective study has just finished in October 2018 and at the stage of data 
analysis. By that time, we aim to examine our hypothesis that relapse of TB is more 
common than re-infection among HIV-infected patients with TB recurrence and investigate 
 120 
 
the relative contribution of relapse and re-infection to disease recurrence. One of critical 
challenges in our prospective trial is high rate of cases lost to follow up as many HIV-
infected patients enrolled in the study are drug abusers. They often change their phone 
number and residency address and quit TB treatment. Their ART is perceived to be a higher 
priority even when TB treatment is provided for free. The cost of TB treatment for 
households presents another major challenge for research studies like ours. The ultimate 
cost of TB treatment for HIV-coinfected individuals can be equal to as much as one year 
of average income in Vietnam; this is due to costs associated with hospital stays and 
additional nutritional needs during treatment.  
Vietnam has successfully reached the 2015 Millennium Development Goal of 
reducing the rate of new TB infections and recently implemented Zero TB Vietnam. 
Recently, Vietnam is also one of the leading countries in paving the way for nations in the 
Western Pacific Region, as well as around the world, in community-based tuberculosis 
prevention. However, due to decreased domestic and international funding, detection and 
treatment of TB represents a serious challenge to attaining prevalence and mortality targets 
set by the Vietnam National Tuberculosis Program (NTP). TB detection and management 
among HIV positive patients also difficult. This requires enhanced clinical capacity, better 
collaboration and coordination between established HIV and TB systems, and laboratory 
strengthening from the central level to the primary health care level. Local funding is 
limited to basic operational needs; namely provision of drugs and TB testing commodities. 
With decreasing international funds for HIV/AIDS control program, it is necessary to 
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improve the effectiveness of current programs that are focussed on helping the NTP and 
the Vietnam Authority of HIV/AIDS Control detect TB earlier, improve TB treatment, 
enhance the laboratory network, and prevent TB transmission in people living with HIV. 
More programs should be implemented for the TB and HIV collaboration such as 
expansion of the number of centres with capacity to provide fully HIV screening in TB 
patients, drug-resistant TB detection and treatment; rapid testing to confirm TB and drug-
resistant TB; more effective monitor program for TB/HIV co-infection patients throughout 
both programs.  
In conclusion, this thesis made the contribution to the understanding of current 
tuberculosis and HIV co-infection in high incidence countries and strengthened the 
argument for using genome sequencing in enhancing both translational research in 
tuberculosis control and the system level interventions to improve the quality and outcome.  
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Supplemental data of Genotypes of 200 strains using 24 MIRU-VNTR 
ID Lineage 154 424 577 580 802 960 1644 1955 2059 2163b 2165 2347 2401 2461 2531 2687 2996 3007 3171 3192 3690 4052 4156 4348 
1 Beijing 2 4 4 2 3 3 3 7 0 6 4 4 4 2 5 1 6 2 2 5 3 3 0 3 
2 U 3 4 4 2 3 4 3 8 2 6 6 4 4 4 5 2 7 3 3 5 4 4 2 3 
3 Beijing 2 4 4 2 3 3 3 8 2 7 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
4 Beijing 2 4 4 2 3 3 3 8 2 6 4 4 4 2 5 1 7 3 3 5 5 5 2 3 
5 U 2 4 4 1 3 3 3 4 2 7 4 4 4 2 5 1 7 4 3 5 3 3 4 3 
6 U 2 2 4 6 3 3 2 7 2 2 7 3 2 3 4 2 2 3 3 5 4 4 1 3 
7 U 2 3 3 2 1 3 3 2 2 5 3 4 4 3 5 1 6 3 3 3 2 2 3 2 
8 Beijing 2 4 4 2 3 3 3 5 2 4 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
9 U 2 5 4 2 3 8 2 4 2 8 5 4 2 3 5 1 5 3 3 3 1 1 1 3 
10 EAI 3 2 4 6 3 4 2 5 2 2 7 3 2 4 5 2 2 3 3 5 4 4 1 3 
11 Beijing 2 3 4 2 3 3 3 5 2 5 4 2 4 2 5 1 7 3 3 5 3 3 2 3 
12 U 2 4 4 2 3 2 3 5 2 6 4 4 4 2 5 1 7 3 3 5 3 3 2 4 
13 U 2 3 4 2 2 2 3 2 2 5 3 4 2 2 5 1 5 3 3 2 3 3 2 2 
14 Beijing 2 4 4 2 3 2 3 5 2 5 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
15 U 2 2 4 2 3 3 3 3 2 3 4 4 2 2 1 4 4 3 3 3 5 5 2 2 
16 EAI 2 1 4 6 2 4 3 11 2 1 5 3 2 6 6 2 2 3 3 4 2 2 1 3 
17 U 2 1 8 5 1 4 2 5 2 2 2 3 2 3 6 4 2 3 3 5 4 4 1 3 
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18 U 2 4 4 2 3 2 3 5 2 6 4 4 4 2 5 1 7 3 3 4 3 3 2 4 
19 Beijing 2 4 4 2 1 3 3 5 2 5 4 4 4 2 6 1 7 2 3 5 2 2 2 3 
20 Beijing 2 4 4 2 3 3 3 5 2 5 3 4 2 2 5 1 7 3 3 5 3 3 2 3 
21 Beijing 2 4 4 2 1 3 3 5 2 5 4 4 4 2 5 1 7 1 3 5 3 3 2 3 
22 U 2 4 10 2 2 2 2 1 2 9 7 4 2 2 5 1 5 2 3 3 1 1 2 2 
23 Beijing 2 3 4 2 3 3 3 4 2 5 4 2 4 2 5 1 7 3 2 5 3 3 2 3 
24 EAI 2 2 4 6 3 4 2 5 2 2 7 3 2 4 5 4 2 3 3 4 4 4 1 3 
25 EAI 3 2 4 6 3 4 2 5 2 2 7 3 2 4 5 4 2 3 3 5 4 4 1 3 
26 EAI 3 2 4 6 3 4 2 5 2 2 7 3 2 4 5 4 2 3 3 5 4 4 1 3 
27 Beijing 2 4 4 2 3 3 3 4 2 6 4 4 4 2 5 1 6 3 3 5 3 3 2 5 
28 U 2 4 4 2 3 3 3 8 2 6 4 4 4 2 5 1 6 3 3 5 3 3 2 5 
29 Beijing 2 4 4 2 3 3 3 4 2 6 4 4 4 2 5 1 6 3 3 5 3 3 2 5 
30 Beijing 2 4 4 2 3 3 3 5 2 5 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
31 U 2 2 4 2 1 3 3 4 2 3 4 4 4 2 5 1 7 3 3 5 3 3 3 3 
32 Beijing 2 3 4 2 3 3 3 5 2 5 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
33 Beijing 2 4 4 2 3 3 3 6 2 6 4 4 4 2 5 1 4 3 3 5 3 3 2 3 
34 Beijing 2 4 4 2 3 2 3 5 2 6 4 4 2 2 5 1 7 3 3 5 3 3 2 4 
35 U 2 2 2 6 2 4 3 9 2 3 9 3 2 4 6 3 2 4 3 6 5 5 1 1 
36 Beijing 2 4 4 2 3 2 3 5 2 5 4 4 4 2 5 4 7 3 3 4 3 3 2 4 
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37 Beijing 2 4 4 2 3 3 3 5 2 5 4 4 4 2 5 1 6 3 3 5 3 3 2 3 
38 U 2 2 2 6 2 4 3 11 2 3 9 3 2 4 6 4 2 4 3 6 5 5 1 1 
39 Beijing 2 4 4 2 3 2 3 5 2 6 4 6 4 2 5 1 7 3 3 5 3 3 2 3 
40 U 2 3 4 2 3 2 3 5 2 2 7 4 4 4 5 2 2 3 3 6 4 4 2 4 
41 Beijing 2 4 4 2 3 3 3 5 2 6 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
42 Beijing 2 4 4 1 3 3 3 4 2 4 4 4 4 2 3 1 7 4 3 5 3 3 4 3 
43 Beijing 2 4 4 2 3 3 3 8 2 6 4 4 4 2 5 1 7 3 3 5 4 4 3 3 
44 EAI 2 2 4 5 3 4 2 7 2 10 10 3 2 4 5 2 2 3 3 4 6 6 1 3 
45 Beijing 2 4 4 2 3 3 3 5 2 6 4 4 4 2 5 1 7 3 3 5 4 4 2 3 
46 Beijing 2 4 4 2 3 3 3 5 2 6 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
47 U 2 3 3 2 5 5 3 3 1 3 3 2 2 2 5 1 6 3 2 3 3 3 3 2 
48 Haarlem 2 2 3 2 3 5 3 3 2 4 3 4 4 2 5 1 5 3 3 3 4 4 3 2 
49 EAI 2 2 4 6 3 3 2 7 2 2 7 3 2 3 4 4 2 3 3 5 4 4 1 3 
50 Beijing 2 4 4 2 3 3 3 8 2 5 4 4 4 2 5 4 7 3 3 6 4 4 2 3 
51 Beijing 2 4 4 2 3 3 3 5 2 6 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
52 Beijing 2 4 4 2 3 3 3 8 2 6 4 4 4 2 5 1 7 3 3 5 5 5 2 3 
53 U 2 3 3 2 1 3 3 2 2 5 3 4 4 3 5 1 6 3 3 3 2 2 3 2 
54 Beijing 2 4 4 2 3 3 3 8 2 6 4 4 4 2 5 1 7 3 3 5 5 5 2 3 
55 U 2 3 3 2 1 3 3 2 2 5 3 4 4 3 5 4 6 3 3 3 2 2 3 2 
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56 U 2 2 4 5 1 4 2 7 2 10 10 4 2 2 5 2 2 3 3 4 6 6 1 3 
57 Beijing 2 4 4 2 3 3 3 5 2 6 4 4 4 2 5 1 7 3 3 5 4 4 2 3 
58 Beijing 2 4 4 2 3 2 3 5 2 5 4 2 4 2 5 1 7 3 2 5 3 3 2 4 
59 EAI 2 4 4 6 3 4 3 5 2 2 7 4 4 4 5 2 6 3 3 5 3 3 2 3 
60 Beijing 2 4 4 2 3 3 3 5 2 5 4 4 4 2 5 1 7 3 4 5 3 3 2 3 
61 Beijing 2 4 4 3 3 3 3 5 2 5 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
62 Beijing 2 4 4 2 3 4 3 3 2 6 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
63 EAI 2 2 4 6 3 4 2 5 2 2 7 3 2 4 5 2 2 3 3 5 4 4 1 3 
64 Beijing 2 4 4 2 3 5 3 4 2 6 7 4 4 2 5 1 6 3 3 5 3 3 2 3 
65 U 2 4 4 2 3 8 2 4 2 8 5 4 2 2 5 1 7 3 3 4 1 1 1 3 
66 Beijing 2 3 4 2 3 3 2 4 2 8 7 4 4 2 5 1 7 3 3 4 3 3 3 3 
67 EAI 3 2 4 9 3 4 2 5 2 2 7 3 2 4 6 2 2 3 3 5 4 4 1 3 
68 Beijing 2 4 5 2 3 3 3 5 2 6 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
69 U 3 4 4 6 3 4 3 5 2 5 7 4 4 4 5 2 7 3 3 5 4 4 2 3 
70 Beijing 2 4 4 2 3 3 3 4 2 7 7 4 4 2 5 1 6 3 3 5 3 3 2 3 
71 U 2 4 4 2 3 4 2 4 2 8 5 4 2 3 5 1 10 3 3 4 1 1 1 3 
72 Beijing 2 4 4 2 1 3 3 5 2 5 4 4 4 3 6 1 7 1 3 5 2 2 2 3 
73 Beijing 2 4 4 2 3 3 3 7 2 6 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
74 Beijing 2 4 4 2 3 3 3 5 2 5 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
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75 Beijing 2 3 4 2 3 2 3 5 2 6 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
76 Beijing 2 4 4 2 3 3 3 8 2 6 4 4 4 2 5 1 7 3 3 5 3 3 2 4 
77 U 2 3 3 2 1 3 3 2 2 5 3 4 4 3 5 1 6 3 3 3 4 4 3 2 
78 Beijing 2 4 4 2 3 3 3 4 2 6 4 4 4 2 5 1 6 3 3 5 3 3 2 3 
79 EAI 3 2 4 6 3 4 2 5 2 2 7 3 2 4 5 2 2 3 3 5 4 4 1 3 
80 Beijing 2 4 4 2 3 2 3 5 2 5 4 4 4 2 5 1 7 3 3 5 3 3 2 4 
81 Beijing 2 4 4 2 3 2 3 5 2 6 4 2 4 2 5 1 7 3 2 5 3 3 2 4 
82 Beijing 2 4 4 2 3 3 3 4 2 6 4 4 4 2 5 1 6 3 3 5 3 3 2 3 
83 Beijing 2 4 4 2 3 3 3 5 2 5 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
84 Beijing 2 6 4 2 3 3 3 5 2 6 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
85 Beijing 2 4 4 2 3 2 3 5 2 6 4 4 4 2 5 1 7 3 3 5 3 3 2 4 
86 EAI 3 2 4 5 3 4 2 5 2 2 7 3 2 4 5 2 2 3 3 5 6 6 1 3 
87 Beijing 2 4 4 2 3 3 3 5 2 6 4 4 4 2 3 1 5 3 3 5 5 5 2 3 
88 Beijing 2 4 4 2 3 2 3 5 2 6 4 4 2 2 5 1 7 3 3 5 3 3 2 4 
89 EAI 2 2 4 6 4 4 2 3 2 2 7 3 2 4 5 2 2 3 3 5 4 4 1 3 
90 Beijing 2 4 4 2 3 3 3 5 2 4 3 4 2 2 5 1 9 3 3 5 4 4 2 3 
91 U 2 4 4 2 3 2 3 5 2 5 12 4 4 2 5 1 7 3 3 5 3 3 2 3 
92 Beijing 2 5 4 2 3 2 3 5 2 6 4 4 2 2 5 1 7 3 3 5 3 3 2 4 
93 Haarlem 2 2 4 2 3 2 3 3 2 3 3 3 2 1 5 1 5 2 3 3 3 3 1 2 
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94 EAI 3 2 4 6 3 4 2 5 2 2 7 3 2 4 5 4 2 2 3 5 7 7 1 3 
95 Beijing 2 4 4 3 1 3 3 5 2 5 4 4 4 2 6 1 7 2 3 5 2 2 2 3 
96 EAI 2 1 4 3 2 4 3 6 2 8 4 3 2 6 6 4 2 2 3 4 7 7 1 3 
97 U 2 1 4 5 3 4 2 5 2 2 5 4 2 4 5 2 2 2 3 6 4 4 1 3 
98 Beijing 2 4 4 2 3 3 3 5 2 3 3 4 4 2 5 1 6 2 3 5 3 3 2 3 
99 EAI 2 1 4 5 2 4 3 10 2 9 4 3 2 6 6 2 2 2 3 4 2 2 1 3 
100 EAI 2 2 4 4 2 4 2 5 2 2 7 3 2 4 5 2 2 2 3 5 5 5 1 2 
101 EAI 2 2 4 6 3 3 2 4 2 2 5 3 2 4 5 2 2 0 3 5 4 4 1 3 
102 EAI 2 2 4 5 3 4 2 5 2 2 6 3 2 4 5 4 2 2 3 4 4 4 1 3 
103 Beijing 2 2 4 2 3 2 3 5 2 5 4 4 4 2 5 1 7 2 3 5 3 3 2 3 
104 Beijing 2 4 4 2 3 2 3 5 2 6 4 4 4 2 5 1 7 2 3 5 3 3 2 3 
105 Beijing 2 4 4 2 3 2 3 5 2 6 4 4 4 2 5 4 7 3 3 5 4 4 2 4 
106 U 2 2 4 2 2 3 3 4 2 7 2 4 4 2 5 4 7 2 3 5 3 3 4 3 
107 EAI 2 2 4 6 3 3 2 5 2 2 7 3 2 3 5 4 2 2 3 5 4 4 1 3 
108 Beijing 2 4 4 2 3 3 3 3 2 6 3 4 4 2 5 1 7 2 3 5 1 1 2 3 
109 Haarlem 2 2 4 2 2 5 1 3 2 1 3 4 4 2 5 1 1 2 3 3 3 3 3 2 
110 EAI 3 2 4 6 3 4 2 5 2 2 7 3 2 4 5 2 2 2 3 5 4 4 1 3 
111 EAI 2 2 4 6 3 3 2 4 2 2 5 3 2 4 5 2 2 2 3 5 4 4 1 3 
112 U 2 4 4 2 3 3 3 5 2 1 4 4 4 2 5 1 8 2 3 5 3 3 2 3 
 151 
 
113 Beijing 2 4 4 2 3 3 3 5 2 5 4 4 4 2 5 1 7 2 3 5 3 3 2 3 
114 EAI 3 2 4 6 3 2 3 5 2 2 7 3 2 4 5 2 2 2 3 5 4 4 1 3 
115 EAI 2 2 4 7 3 3 2 4 2 2 7 3 2 5 5 2 2 2 3 5 4 4 1 3 
116 Beijing 2 4 4 2 2 3 3 6 2 5 4 4 4 2 5 1 7 2 3 5 3 3 2 3 
117 U 2 2 4 1 2 4 2 5 2 2 7 3 2 3 5 2 2 2 3 5 4 4 1 3 
118 Beijing 2 4 4 2 3 3 3 5 2 6 4 4 4 2 5 1 7 2 3 5 3 3 2 3 
119 Beijing 2 4 4 2 3 3 3 5 2 6 4 4 4 2 5 1 7 2 3 6 3 3 2 3 
120 Haarlem 2 2 4 2 2 5 1 3 2 1 3 4 4 2 5 1 1 2 3 3 3 3 3 2 
121 EAI 2 2 4 6 3 3 2 5 2 2 7 3 2 4 5 2 2 2 3 5 4 4 1 3 
122 U 2 2 4 2 2 5 1 3 2 1 3 4 4 2 5 1 1 2 3 3 5 5 3 2 
123 EAI 2 2 4 6 2 5 2 5 2 2 7 3 2 4 5 2 2 2 3 5 4 4 1 3 
124 Beijing 2 4 4 2 3 3 3 5 2 6 4 4 4 2 3 1 5 2 3 5 5 5 2 3 
125 U 2 4 4 2 4 9 2 4 2 6 5 4 2 2 5 1 5 2 2 4 1 1 1 3 
126 EAI 3 2 4 10 3 4 2 5 2 2 7 3 2 4 6 2 2 2 3 5 4 4 1 3 
127 U 2 4 3 2 3 5 3 4 2 5 4 4 4 2 5 1 6 2 3 5 3 3 3 3 
128 EAI 2 2 4 6 2 4 2 7 2 2 7 3 2 4 5 4 2 2 3 5 4 4 1 3 
129 EAI 2 2 4 5 3 4 2 5 2 2 5 3 2 4 5 4 2 2 3 5 4 4 1 3 
130 U 2 4 2 2 3 8 2 4 2 6 5 4 2 2 5 1 6 2 3 3 1 1 1 3 
131 Beijing 2 4 4 2 3 3 3 5 2 6 4 4 4 2 5 1 7 2 3 5 3 3 2 3 
 152 
 
132 EAI 2 2 4 8 2 4 2 5 2 2 7 3 2 4 5 4 2 2 3 5 4 4 1 3 
133 EAI 2 2 4 5 3 4 3 6 2 2 6 3 2 4 5 4 2 2 3 5 4 4 1 3 
134 EAI 2 2 4 6 2 4 2 7 2 2 7 3 2 4 5 4 2 2 3 5 4 4 1 3 
135 Beijing 2 4 4 2 3 4 3 4 2 5 4 4 4 2 5 1 7 0 3 5 3 3 2 3 
136 U 3 2 5 5 3 4 2 5 2 2 7 3 2 4 5 4 2 2 3 5 4 4 1 4 
137 EAI 2 2 4 6 3 4 2 5 2 2 7 3 2 4 5 4 2 2 3 7 5 5 1 3 
138 EAI 2 2 4 5 3 4 2 5 2 2 5 3 2 4 6 2 2 2 3 5 4 4 1 3 
139 Beijing 2 4 4 2 3 3 3 5 2 3 4 4 4 2 5 1 7 2 2 5 3 3 2 3 
140 Beijing 2 3 4 2 3 3 3 4 2 4 4 4 4 2 5 1 7 2 3 5 2 2 2 3 
141 EAI 2 2 4 3 3 4 1 6 2 2 7 3 2 4 5 2 2 2 3 5 4 4 1 3 
142 NEW-1 2 2 4 2 3 2 3 3 2 3 3 4 2 1 4 1 5 2 3 3 3 3 2 2 
143 U 2 4 4 2 3 4 3 5 2 2 7 4 4 4 5 2 7 2 3 5 3 3 2 3 
144 U 2 2 4 2 3 2 3 4 2 3 3 2 2 1 4 1 4 2 3 3 3 3 2 2 
145 U 2 2 4 2 2 4 4 2 2 3 2 4 2 2 5 1 5 2 2 3 3 3 2 2 
146 Beijing 2 4 4 2 3 3 3 5 2 5 4 4 4 2 5 1 7 2 3 5 3 3 2 3 
147 Beijing 2 4 4 2 3 3 3 5 2 6 4 4 4 2 5 1 7 2 3 5 4 4 1 3 
148 EAI 2 2 4 6 3 4 2 5 2 2 2 3 2 4 5 2 2 2 3 5 6 6 1 3 
149 EAI 2 2 4 5 1 4 2 6 2 2 7 3 2 4 6 2 2 2 3 4 4 4 1 3 
150 Beijing 2 4 4 2 3 3 3 4 2 7 4 4 4 2 5 1 7 3 3 5 4 4 4 3 
 153 
 
151 Beijing 2 3 4 2 3 3 3 4 2 5 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
152 Beijing 2 4 4 2 3 2 3 5 2 6 3 4 4 2 5 1 7 3 3 5 3 3 2 4 
153 Haarlem 2 0 3 2 3 5 3 3 2 5 3 4 4 2 5 1 5 3 3 3 3 3 3 2 
154 EAI 3 2 4 6 3 4 2 5 2 2 7 3 2 4 5 2 2 3 3 5 4 4 1 3 
155 Beijing 2 3 4 2 1 2 3 3 2 7 4 4 4 2 5 1 7 3 3 5 3 3 3 2 
156 U 2 3 4 2 1 2 3 3 3 7 4 4 4 2 5 0 7 0 3 5 3 3 3 2 
157 EAI 3 2 4 6 3 4 2 5 3 1 7 3 2 4 5 5 2 9 3 5 4 4 2 3 
158 EAI 3 2 4 7 3 4 2 5 3 2 7 3 2 4 5 5 2 9 3 5 4 4 1 3 
159 Beijing 2 4 4 2 3 3 3 5 4 6 4 4 4 2 5 0 7 0 3 5 3 3 2 3 
160 EAI 3 2 4 6 2 4 2 5 3 2 7 3 2 4 5 5 2 11 3 5 4 4 1 3 
161 U 3 2 4 6 3 4 2 5 3 2 7 3 2 4 5 0 2 9 3 6 4 4 1 3 
162 Beijing 2 4 2 2 3 3 3 5 2 6 4 4 4 2 5 1 6 3 3 5 3 3 1 3 
163 EAI 2 2 4 5 3 3 2 4 2 2 7 3 2 4 5 2 2 3 3 5 4 4 1 3 
164 EAI 2 2 4 5 3 3 2 5 2 2 7 3 2 4 5 2 2 3 3 5 4 4 1 3 
165 EAI 2 2 4 5 3 4 3 6 2 2 7 3 2 4 5 2 2 3 3 5 4 4 1 3 
166 LAM 2 4 4 2 1 4 2 3 2 3 2 4 1 2 6 2 5 3 3 5 1 1 2 2 
167 Beijing 2 4 4 2 3 3 3 5 2 6 4 4 4 2 5 1 7 3 3 5 3 3 2 3 
168 Beijing 2 4 4 2 3 3 3 4 2 7 4 4 4 2 5 1 7 3 3 5 3 3 1 3 
169 U 3 2 4 6 3 4 2 4 2 2 7 3 2 4 5 4 2 3 3 5 4 4 1 3 
 154 
 
170 Beijing 2 4 5 2 3 3 3 5 2 5 4 4 4 2 5 4 7 3 3 5 3 3 2 3 
171 EAI 2 2 4 4 7 3 2 5 2 2 7 3 2 4 5 4 3 3 3 5 4 4 1 3 
172 Beijing 2 4 4 2 1 3 3 5 2 5 4 4 4 2 6 3 7 2 3 5 2 2 2 3 
173 Beijing 2 5 4 2 3 4 3 5 2 5 4 4 4 2 5 1 7 3 3 4 3 3 2 3 
174 EAI 2 2 4 6 3 3 2 5 2 2 7 3 2 4 5 2 2 3 3 5 4 4 1 3 
175 Beijing 2 4 4 2 1 3 3 5 2 2 4 4 4 2 6 1 7 1 3 5 2 2 2 3 
176 EAI 2 2 4 6 3 3 2 5 2 2 7 3 2 3 5 4 2 3 3 5 4 4 1 3 
177 Beijing 2 4 4 2 3 2 3 5 2 6 4 4 4 2 5 1 7 3 3 5 3 3 2 4 
178 Beijing 2 4 4 2 3 2 3 5 2 6 4 4 4 2 5 1 7 3 3 5 3 3 2 4 
179 EAI 3 2 4 6 3 5 2 3 2 2 7 3 2 4 5 4 2 3 3 5 4 4 1 3 
180 EAI 2 2 4 6 3 3 2 5 2 2 7 3 2 4 5 4 2 3 3 5 6 6 1 3 
181 EAI 2 2 4 6 3 4 2 6 2 2 7 3 2 4 5 4 2 3 3 5 4 4 1 3 
182 Beijing 2 4 4 2 1 3 1 5 2 5 4 4 4 2 5 4 8 2 3 5 3 3 2 3 
183 EAI 2 2 4 5 3 4 2 5 2 2 6 3 2 4 5 4 2 3 3 5 4 4 1 3 
184 U 3 2 4 6 3 4 1 5 2 2 6 3 2 4 5 2 2 3 3 5 4 4 1 3 
185 Beijing 2 5 4 2 3 3 3 4 2 3 4 4 3 2 5 1 4 3 3 5 3 3 4 3 
186 EAI 2 1 4 5 2 4 3 10 2 4 4 3 2 6 6 4 2 3 3 4 2 2 1 3 
187 Beijing 2 4 4 2 3 2 3 5 2 5 4 4 4 2 5 4 7 3 3 5 3 3 2 3 
188 Beijing 2 4 4 2 3 3 3 5 2 7 7 4 2 2 5 4 7 3 3 5 3 3 2 3 
 155 
 
189 Beijing 2 4 4 2 3 3 3 4 2 6 4 4 4 2 5 1 6 3 3 5 3 3 2 3 
190 EAI 2 3 4 6 3 4 2 4 2 2 7 3 2 4 5 4 2 3 3 5 4 4 1 3 
191 EAI 2 2 4 6 3 4 2 5 2 2 7 3 2 3 5 4 2 3 3 5 4 4 1 3 
192 EAI 2 2 4 6 1 4 2 5 2 2 7 3 2 4 5 4 2 3 3 5 4 4 1 3 
193 U 2 2 4 6 2 4 2 6 2 2 7 3 2 4 5 4 2 3 3 5 4 4 1 3 
194 Beijing 2 4 4 2 3 2 3 5 2 6 4 4 4 2 5 4 7 3 3 5 3 3 2 3 
195 Beijing 2 4 4 2 1 3 3 5 2 5 4 4 4 2 5 3 8 2 3 5 3 3 2 3 
196 EAI 2 2 4 6 3 3 2 4 2 2 7 3 2 4 5 2 2 3 3 5 4 4 1 3 
197 Beijing 2 4 6 2 3 3 3 5 2 6 5 4 4 2 5 5 7 3 2 5 4 4 2 3 
198 EAI 2 2 4 6 3 3 2 5 2 2 7 3 2 4 10 4 2 3 3 5 4 4 1 3 
199 Beijing 2 4 6 2 5 2 3 5 2 6 5 4 4 2 5 5 4 5 3 5 3 3 2 4 
200 Beijing 2 4 6 2 3 3 3 6 2 5 5 4 4 2 5 1 7 3 3 5 8 8 2 3 
 
